<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Toxins (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Toxins (Basel)</journal-id><journal-id journal-id-type="publisher-id">toxins</journal-id><journal-title-group><journal-title>Toxins</journal-title></journal-title-group><issn pub-type="epub">2072-6651</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5744110</article-id><article-id pub-id-type="doi">10.3390/toxins9120390</article-id><article-id pub-id-type="publisher-id">toxins-09-00390</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Targeting Metastasis with Snake Toxins: Molecular Mechanisms</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Urra</surname><given-names>F&#x000e9;lix A.</given-names></name><xref ref-type="aff" rid="af1-toxins-09-00390">1</xref><xref ref-type="aff" rid="af2-toxins-09-00390">2</xref><xref rid="c1-toxins-09-00390" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5082-9146</contrib-id><name><surname>Araya-Maturana</surname><given-names>Ramiro</given-names></name><xref ref-type="aff" rid="af3-toxins-09-00390">3</xref><xref rid="c1-toxins-09-00390" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Peigneur</surname><given-names>Steve</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-toxins-09-00390"><label>1</label>Anatomy and Developmental Biology Program, Institute of Biomedical Sciences, University of Chile, Independencia 1027, Casilla 7, Santiago 7800003, Chile</aff><aff id="af2-toxins-09-00390"><label>2</label>Geroscience Center for Brain Health and Metabolism, Independencia 1027, Casilla 7, Santiago 7800003, Chile</aff><aff id="af3-toxins-09-00390"><label>3</label>Instituto de Qu&#x000ed;mica de Recursos Naturales, Universidad de Talca, Casilla 747, Talca 3460000, Chile</aff><author-notes><corresp id="c1-toxins-09-00390"><label>*</label>Correspondence: <email>felix.urra@qf.uchile.cl</email> (F.A.U.); <email>raraya@utalca.cl</email> (R.A.-M.); Tel.: +56-22-978-9580 (F.A.U.); +56-71-220-0285 (R.A.-M.)</corresp></author-notes><pub-date pub-type="epub"><day>30</day><month>11</month><year>2017</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2017</year></pub-date><volume>9</volume><issue>12</issue><elocation-id>390</elocation-id><history><date date-type="received"><day>02</day><month>11</month><year>2017</year></date><date date-type="accepted"><day>28</day><month>11</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; 2017 by the authors.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Metastasis involves the migration of cancer cells from a primary tumor to invade and establish secondary tumors in distant organs, and it is the main cause for cancer-related deaths. Currently, the conventional cytostatic drugs target the proliferation of malignant cells, being ineffective in metastatic disease. This highlights the need to find new anti-metastatic drugs. Toxins isolated from snake venoms are a natural source of potentially useful molecular scaffolds to obtain agents with anti-migratory and anti-invasive effects in cancer cells. While there is greater evidence concerning the mechanisms of cell death induction of several snake toxin classes on cancer cells; only a reduced number of toxin classes have been reported (i.e., disintegrins/disintegrin-like proteins, C-type lectin-like proteins, C-type lectins, serinproteases, cardiotoxins, snake venom cystatins) as inhibitors of adhesion, migration, and invasion of cancer cells. Here, we discuss the anti-metastatic mechanisms of snake toxins, distinguishing three targets, which involve (1) inhibition of extracellular matrix components-dependent adhesion and migration, (2) inhibition of epithelial-mesenchymal transition, and (3) inhibition of migration by alterations in the actin/cytoskeleton network.</p></abstract><kwd-group><kwd>anti-cancer agents</kwd><kwd>cancer cells</kwd><kwd>invasion</kwd><kwd>migrastatic drugs</kwd><kwd>snake venom</kwd></kwd-group></article-meta></front><body><sec id="sec1-toxins-09-00390"><title>1. Introduction</title><p>Currently, anticancer therapies target the uncontrolled clonal proliferation of cancer cells with cytostatic drugs, which are an effective therapeutic strategy for certain cancer types such as hematological malignancies. However, in solid cancers, the proliferation is accompanied by the ability to invade and execute metastasis, involving different molecular mechanisms that are not inhibited or affected by conventional anti-cancer drugs. Therefore, to search for and design specific drugs to inhibit invasion and metastasis for treatment of solid cancers is a highly relevant issue [<xref rid="B1-toxins-09-00390" ref-type="bibr">1</xref>].</p><p>The composition of solid tumors is heterogeneous, having several cancer cell subpopulations with different tumorigenic properties [<xref rid="B2-toxins-09-00390" ref-type="bibr">2</xref>]. In a tumor, cancer cells acquire mutations that confer them with different proliferative capacities and survival advantages. A subpopulation, named metastasis-initiating cells (MICs), exhibits high plasticity to adapt their metabolic and proliferative requirements, ability to enter and exit dormancy state, and resistance to apoptosis and immune evasion, which is responsible for metastatic growth [<xref rid="B3-toxins-09-00390" ref-type="bibr">3</xref>]. For example, during the initial steps of tumor growth of cancer cells confined to epithelium, certain colonies of malignant cells can form a carcinoma in situ separated from the stroma. In some cells, mutations provide the ability to establish a physical relationship with stroma and changes in extracellular signals from the microenvironment, triggering the secretion of soluble factors by stromal and hematopoietic cells [<xref rid="B4-toxins-09-00390" ref-type="bibr">4</xref>,<xref rid="B5-toxins-09-00390" ref-type="bibr">5</xref>] and inducing phenotypic changes in cancer cells known as epithelial&#x02013;mesenchymal transition (EMT). This process recapitulates properties displayed by tissues during the embrionary development [<xref rid="B6-toxins-09-00390" ref-type="bibr">6</xref>] that facilitate the dissociation of cancer cell from the tumor bulk and dissemination to distant organs, being considered a prerequisite for invasion and metastasis [<xref rid="B2-toxins-09-00390" ref-type="bibr">2</xref>,<xref rid="B7-toxins-09-00390" ref-type="bibr">7</xref>].</p><p>Metastasis is a complex process in which cancer cells disseminate from a primary tumor to invade a distant organ, this ability characterizes the tumor malignancy [<xref rid="B6-toxins-09-00390" ref-type="bibr">6</xref>]. It has been described that about 90% of cancer-related deaths are caused by a metastatic disease [<xref rid="B8-toxins-09-00390" ref-type="bibr">8</xref>]. It is clear that dissemination to specific organs depends upon blood flow patterns and of the relationship of the migrating cells with distant organ microenvironments, the stromal cell content, vascular architecture, presence of growth factors, metabolic substrates, and signaling molecules. These characteristics can be permissive or antagonistic to metastatic colonization, determining whether these cells grow to form secondary tumors [<xref rid="B9-toxins-09-00390" ref-type="bibr">9</xref>].</p><p>The detailed mechanistic insight of the metastatic process contrast with the minimal progress in the identification of effective therapeutic targets and in the design of new anti-metastatic drugs [<xref rid="B1-toxins-09-00390" ref-type="bibr">1</xref>]. Based on structural characteristics and their known interactions with macromolecules, toxins isolated from snake venoms may represent a natural source of molecular scaffolds to obtain agents with anti-migratory and anti-invasive effects in cancer cells. In this review, we summarize recent evidence on the inhibitory effect of snake toxins on adhesion, migration, and invasion of cancer cells.</p></sec><sec id="sec2-toxins-09-00390"><title>2. Snake Toxins as Inhibitors of Cancer Metastasis</title><p>There is ample literature showing that several isolated or recombinant snake venom toxins exhibit anti-cancer effects in vitro and in vivo preclinical models, inducing cell death via mitochondrial apoptotic pathway (intrinsic pathway) or necrosis [<xref rid="B10-toxins-09-00390" ref-type="bibr">10</xref>,<xref rid="B11-toxins-09-00390" ref-type="bibr">11</xref>,<xref rid="B12-toxins-09-00390" ref-type="bibr">12</xref>]. In addition, certain toxins such as snake venom metalloproteases (SVMPs), disintegrins, phospholipases A2, C-type lectins (CLP), vascular apoptosis inducing proteins, and L-amino acid oxidases are able to inhibit angiogenesis [<xref rid="B13-toxins-09-00390" ref-type="bibr">13</xref>,<xref rid="B14-toxins-09-00390" ref-type="bibr">14</xref>,<xref rid="B15-toxins-09-00390" ref-type="bibr">15</xref>] and activate the immune response during tumorigenesis [<xref rid="B16-toxins-09-00390" ref-type="bibr">16</xref>]. While greater evidence on mechanisms of death induction of snake toxins on cancer cells have been reported, reduced information on the inhibitory mechanisms of adhesion, migration, and invasion of metastatic cancer cells is available. Despite the aforementioned information, it is possible distinguish three anti-metastatic mechanisms exhibited by at least six different snake toxin classes (<xref ref-type="fig" rid="toxins-09-00390-f001">Figure 1</xref>): involving (1) inhibition of extracellular matrix components (ECM)-dependent adhesion and migration, (2) inhibition of epithelial-mesenchymal transition, and (3) inhibition of migration by alterations in the actin/cytoskeleton network.</p></sec><sec id="sec3-toxins-09-00390"><title>3. Inhibition of Extracellular Matrix Component-Dependent Adhesion and Migration</title><p>During the initial steps of metastasis, it is required the interaction between ECM components and cancer cell, involving the ability of these cells to adhere to ECM components and migrate through them [<xref rid="B17-toxins-09-00390" ref-type="bibr">17</xref>]. Integrins are the major receptor family present on the cell surface for adhesion to the ECM and include heterodimeric, transmembrane glycoproteins composed of &#x003b1; and &#x003b2; subunits [<xref rid="B18-toxins-09-00390" ref-type="bibr">18</xref>], whose dimerization leads to 24 integrin pairs with distinct extracellular ligand-binding specificities [<xref rid="B18-toxins-09-00390" ref-type="bibr">18</xref>]&#x02014;such as collagen, laminin, vitronectin, and fibronectin&#x02014;through the tripeptide motif Arg-Gly-Asp = RGD [<xref rid="B19-toxins-09-00390" ref-type="bibr">19</xref>]. Abundant evidence has correlated the increased overexpression of certain integrins &#x003b1;v&#x003b2;3, &#x003b1;5&#x003b2;1, and &#x003b1;v&#x003b2;6 with cancer progression [<xref rid="B20-toxins-09-00390" ref-type="bibr">20</xref>,<xref rid="B21-toxins-09-00390" ref-type="bibr">21</xref>,<xref rid="B22-toxins-09-00390" ref-type="bibr">22</xref>]. Integrins activate intracellular signaling that control cytoskeleton organization, cell polarity, and formation of leading edge of migrating cancer cells [<xref rid="B22-toxins-09-00390" ref-type="bibr">22</xref>], being an attractive anti-cancer target for new antagonist molecules [<xref rid="B23-toxins-09-00390" ref-type="bibr">23</xref>,<xref rid="B24-toxins-09-00390" ref-type="bibr">24</xref>].</p><p>Three toxin classes (snake venom disintegrins, C-type lectin-like protein, and Kunit-like serinprotease inhibitor) have been reported with anti-migratory effect mediated by interaction with integrins in cancer cells, which are summarized in <xref ref-type="table" rid="toxins-09-00390-t001">Table 1</xref>.</p><p>Snake venom disintegrins are small non-enzymatic proteins mostly derived from proteolytic processing of precursors that contain a metalloprotease domain, known as snake venom metalloproteases (SVMPs), which are phylogenetically related with ADAMs (a disintegrin and metalloprotease) [<xref rid="B25-toxins-09-00390" ref-type="bibr">25</xref>,<xref rid="B26-toxins-09-00390" ref-type="bibr">26</xref>,<xref rid="B27-toxins-09-00390" ref-type="bibr">27</xref>,<xref rid="B28-toxins-09-00390" ref-type="bibr">28</xref>]. This protein family, commonly found in the venoms of the Viperidae snakes [<xref rid="B26-toxins-09-00390" ref-type="bibr">26</xref>] and some rear-fanged snakes [<xref rid="B28-toxins-09-00390" ref-type="bibr">28</xref>,<xref rid="B29-toxins-09-00390" ref-type="bibr">29</xref>,<xref rid="B30-toxins-09-00390" ref-type="bibr">30</xref>,<xref rid="B31-toxins-09-00390" ref-type="bibr">31</xref>,<xref rid="B32-toxins-09-00390" ref-type="bibr">32</xref>,<xref rid="B33-toxins-09-00390" ref-type="bibr">33</xref>,<xref rid="B34-toxins-09-00390" ref-type="bibr">34</xref>,<xref rid="B35-toxins-09-00390" ref-type="bibr">35</xref>], is classified according to their modular architecture with multiple non-catalytic domains in SVMP P-I, P-II, and P-III classes. Disintegrins are derived from proteolytic processing of P-II SMVP class and usually exhibit the canonical &#x0201c;RDG&#x0201d; integrin-recognition motif; however, non-canonical integrin-binding motif&#x02014;such as &#x0201c;MLD&#x0201d;, &#x0201c;KTS&#x0201d;, and &#x0201c;VGD&#x0201d;&#x02014;are exhibited in some snake venom disintegrins [<xref rid="B36-toxins-09-00390" ref-type="bibr">36</xref>,<xref rid="B37-toxins-09-00390" ref-type="bibr">37</xref>]. In addition, proteolysis from P-III SVMP class originates disintegrin-like proteins, which have covalently bound the &#x0201c;disintegrin-like&#x0201d; and &#x0201c;cysteine (Cys)-rich&#x0201d; domains [<xref rid="B27-toxins-09-00390" ref-type="bibr">27</xref>]. Comprehensive classification and structural characteristics of SVMP are found in Takeda et al., 2012 [<xref rid="B27-toxins-09-00390" ref-type="bibr">27</xref>] and Takeda, 2016 [<xref rid="B38-toxins-09-00390" ref-type="bibr">38</xref>].</p><p>A disintegrin isolated from the venom of the Middle American rattlesnake (<italic>Crotalus simus tzabcan</italic>) named tzabcanin [<xref rid="B39-toxins-09-00390" ref-type="bibr">39</xref>], which has 71 amino acids and contains the canonical RGD-binding domain, exhibits a weak or null cytotoxic effect on cancer cell lines [<xref rid="B39-toxins-09-00390" ref-type="bibr">39</xref>], but remarkable inhibitory effect of fibronectin- and vitronectin-dependent cell adhesion. This toxin binds &#x003b1;v&#x003b2;3-integrins, which is the main receptor of the ECM protein vitronectin, inhibiting the adhesion and migration of melanoma and lung cancer cells [<xref rid="B40-toxins-09-00390" ref-type="bibr">40</xref>].</p><p>DisBa-01, a recombinant RGD-disintegrin produced from a cDNA venom gland library of <italic>Bothrops alternatus</italic>, inhibits in vivo angiogenesis and pulmonary metastasis [<xref rid="B49-toxins-09-00390" ref-type="bibr">49</xref>]. In oral squamous carcinoma cells, DisBa-01 selectively decreases the migration speed and directionality of fibronectin-stimulated migration, increasing the adhesion area and rate of adhesion maturation. It lacks effects on migration of non-malignant cells such as fibroblasts. DisBa-01 exhibits a high affinity on fibronectin binding receptor &#x003b1;v&#x003b2;3 integrin [<xref rid="B43-toxins-09-00390" ref-type="bibr">43</xref>]. Other recombinant disintegrins from Viperidae species have been reported such as &#x003b1;v&#x003b2;3 integrin antagonists, inhibiting the migration of cancer cells (<xref ref-type="table" rid="toxins-09-00390-t001">Table 1</xref>). Additional disintegrins and disintegrin-like proteins from snake venoms reported with anti-cancer effect can be found in Selistre-de-Araujo et al., 2010 [<xref rid="B50-toxins-09-00390" ref-type="bibr">50</xref>].</p><p>Interestingly, Lebecin, and PIVL isolated from <italic>Macrovipera lebetina</italic> venom, which belong two different toxin classes C-type lectin-like protein and Kunitz-type serin protease inhibitor, respectively, exhibit inhibitory effect on fibrinogen- and fibronectin-stimulated adhesion and migration.</p><p>Lebecin is a C-type lectin-like protein with &#x003b1; and &#x003b2; subunits of 129 and 131 amino acids, respectively [<xref rid="B47-toxins-09-00390" ref-type="bibr">47</xref>]. In triple-negative breast cancer MDA-MB-231 cells, lebecin does not affect the viability. However, it inhibits the fibrinogen- and fibronectin-dependent adhesion and migration in a dose-dependent manner [<xref rid="B47-toxins-09-00390" ref-type="bibr">47</xref>]. It has been described that lebecin interacts with &#x003b1;v&#x003b2;3 integrin; but based on the high identity of its amino acid sequence with other C-type lectin-like protein previously reported from <italic>Macrovipera lebetina</italic> venom with inhibitory effect on adhesion, migration, and invasion of cancer cells [<xref rid="B51-toxins-09-00390" ref-type="bibr">51</xref>,<xref rid="B52-toxins-09-00390" ref-type="bibr">52</xref>], it has been suggested that lebecin can block other integrins such as &#x003b1;5&#x003b2;1 [<xref rid="B47-toxins-09-00390" ref-type="bibr">47</xref>].</p><p>PIVL is a monomeric polypeptide chain bound by three disulfide linkages, which inhibits trypsin activity and lacks effects on the viability but blocks &#x003b1;v&#x003b2;3 integrin-dependent migration, affecting the motility and cell directionality persistence of cancer cells [<xref rid="B48-toxins-09-00390" ref-type="bibr">48</xref>]. PIVL also exhibits in vitro and in vivo anti-angiogenic effects [<xref rid="B53-toxins-09-00390" ref-type="bibr">53</xref>].</p></sec><sec id="sec4-toxins-09-00390"><title>4. Inhibition of Epithelial&#x02013;Mesenchymal Transition</title><p>Epithelial&#x02013;mesenchymal transition (EMT) is a process in which epithelial cells transdifferentiate into mesenchymal cells, losing their morphoinmunophenotypic characteristics. Interestingly, EMT occurs in normal and healthy tissues during angiogenesis and lymphangiogenesis; but in certain pathological conditions such as chronic inflammation, fibrosis and cancer is reactivated [<xref rid="B6-toxins-09-00390" ref-type="bibr">6</xref>]. In tumors, EMT-like transitions involve the loss of components related with cell-cell interactions, apico-basal cell polarity and reorganization of cytoskeleton. Cancer cells with EMT have tumorigenic properties that non-EMT cells do not exhibit, such as a high migratory state that promote invasion and metastasis [<xref rid="B4-toxins-09-00390" ref-type="bibr">4</xref>,<xref rid="B5-toxins-09-00390" ref-type="bibr">5</xref>], lacking response to signals of oncogene-induced senescence [<xref rid="B54-toxins-09-00390" ref-type="bibr">54</xref>] and resistance to anti-cancer drugs [<xref rid="B55-toxins-09-00390" ref-type="bibr">55</xref>,<xref rid="B56-toxins-09-00390" ref-type="bibr">56</xref>,<xref rid="B57-toxins-09-00390" ref-type="bibr">57</xref>].</p><p>EMT can be induced by growth factors such as transforming growth factor beta (TGF-&#x003b2;), epidermal growth factor (EGF), hepatocyte growth factor (HGF), insulin-like growth factors 1 and 2 [<xref rid="B40-toxins-09-00390" ref-type="bibr">40</xref>], activating RAS, Notch, and Wnt signalings which have been associated with poor prognosis and cancer progression [<xref rid="B58-toxins-09-00390" ref-type="bibr">58</xref>,<xref rid="B59-toxins-09-00390" ref-type="bibr">59</xref>]. During EMT, there is a reduction of the epithelial marker E-cadherin and an increase of the expression of mesenchymal markers vimentin, N-cadherin [<xref rid="B60-toxins-09-00390" ref-type="bibr">60</xref>], as well as activation of transcription factors Snail, Slug, Twist, which act as repressor of E-cadherin [<xref rid="B5-toxins-09-00390" ref-type="bibr">5</xref>,<xref rid="B61-toxins-09-00390" ref-type="bibr">61</xref>].</p><p>Cardiotoxin III (CTX-III), a membrane toxin from Taiwan cobra (<italic>Naja naja</italic>) venom [<xref rid="B62-toxins-09-00390" ref-type="bibr">62</xref>], inhibits the migration of cancer cells by reversion of EGF- and HGF-induced EMT. Previously, CTX-III has been described as a potent inductor of cell death in several human cancer cell lines [<xref rid="B63-toxins-09-00390" ref-type="bibr">63</xref>,<xref rid="B64-toxins-09-00390" ref-type="bibr">64</xref>,<xref rid="B65-toxins-09-00390" ref-type="bibr">65</xref>] and a migration inhibitor of oral and breast cancer cells through activation of JNK and p38, without effect on ERK signaling, producing decreased metalloproteases-2 and -9 (MMP-2/-9) levels [<xref rid="B66-toxins-09-00390" ref-type="bibr">66</xref>,<xref rid="B67-toxins-09-00390" ref-type="bibr">67</xref>].</p><p>In breast cancer cells, the paracrine role of epidermal growth factor (EGF) and its receptor EGFR (ErbB-1) contribute to invasion, intravasation, and metastasis [<xref rid="B68-toxins-09-00390" ref-type="bibr">68</xref>] through activation of extracellular signal-regulated kinase 1/2 (ERK1/2), STAT3, or PI3K/Akt signaling, promoting the EMT [<xref rid="B69-toxins-09-00390" ref-type="bibr">69</xref>,<xref rid="B70-toxins-09-00390" ref-type="bibr">70</xref>,<xref rid="B71-toxins-09-00390" ref-type="bibr">71</xref>]. CTX-III inhibits the EGF-induced EMT in breast cancer cells, reducing EGFR phosphorylation and activation PI3K/Akt and ERK1/2. It reduces the MMP-9 levels [<xref rid="B72-toxins-09-00390" ref-type="bibr">72</xref>] and the mesenchymal markers vimentin and N-cadherin and increases E-cadherin levels, inhibiting EGF-induced invasion and migration [<xref rid="B72-toxins-09-00390" ref-type="bibr">72</xref>,<xref rid="B73-toxins-09-00390" ref-type="bibr">73</xref>]. A similar effect of CTX-III on hepatocyte growth factor (HGF)-stimulated migration and invasion in breast cancer cells has been described [<xref rid="B73-toxins-09-00390" ref-type="bibr">73</xref>,<xref rid="B74-toxins-09-00390" ref-type="bibr">74</xref>,<xref rid="B75-toxins-09-00390" ref-type="bibr">75</xref>].</p><p>Cancer cells can excrete cysteine-cathepsins, which are endopeptidases located intracellularly in endolysosomal vesicles [<xref rid="B76-toxins-09-00390" ref-type="bibr">76</xref>] that are essential during the breakdown the ECM to promote the invasion and metastasis [<xref rid="B77-toxins-09-00390" ref-type="bibr">77</xref>]. During EMT, cancer cells exhibit an increased extra- and intra-cellular proteolysis mediated by cathepsins, matrix metalloproteinases, urokinase-type plasminogen activator (uPA), and serinproteases such as kallikreins [<xref rid="B78-toxins-09-00390" ref-type="bibr">78</xref>]. This proteolytic activity removes surface molecules involved in cell adhesion such as E-cadherin [<xref rid="B79-toxins-09-00390" ref-type="bibr">79</xref>,<xref rid="B80-toxins-09-00390" ref-type="bibr">80</xref>], limiting the cell&#x02013;cell interaction and remodeling the extracellular matrix to uncover binding epitopes recognized by integrins and to form trials for cell migration [<xref rid="B81-toxins-09-00390" ref-type="bibr">81</xref>]. Cysteine-cathepsins are regulated by natural inhibitors such as cystatins [<xref rid="B82-toxins-09-00390" ref-type="bibr">82</xref>], which represent a group constituted by three types (type 1-stenfins, type-2 cystatins, type 3-kininogens) of cystatin domain containing proteins [<xref rid="B83-toxins-09-00390" ref-type="bibr">83</xref>]. From <italic>Naja naja atra</italic> venom, it has been isolated a snake venom cystatin (Sv-cystatin) that exhibits a shorter sequence than other type-2 cystatins, such as cystatin M and cystatin C [<xref rid="B84-toxins-09-00390" ref-type="bibr">84</xref>]. For this snake toxin, inhibitory effects on invasion and metastasis mediated by reduction of EMT markers has been described in MHCC97H liver cancer cells [<xref rid="B85-toxins-09-00390" ref-type="bibr">85</xref>]. Sv-cystatin decreases the cathepsin B activity, MMP-2, and MMP-9 levels, increasing E-cadherin and decreasing EMT proteins N-cadherin and twist [<xref rid="B85-toxins-09-00390" ref-type="bibr">85</xref>].</p></sec><sec id="sec5-toxins-09-00390"><title>5. Alterations in the Actin/Cytoskeleton Network</title><p>During migration and invasion of cancer cells, the actin cytoskeleton is remodeled under extracellular stimuli, which is mediated by several receptors, including integrins [<xref rid="B19-toxins-09-00390" ref-type="bibr">19</xref>]. Small GTPases Rho, Rac, and Cdc42 participate in the intracellular signaling involved in the control of the actin cytoskeleton architecture required for cell motility in individual and collective migration [<xref rid="B86-toxins-09-00390" ref-type="bibr">86</xref>], which is a common signaling for normal and cancer cells [<xref rid="B2-toxins-09-00390" ref-type="bibr">2</xref>]. The cell protrusion of a leading edge relies on Cdc42 and Rac activities, which are coupled to Rho activity-dependent contractility, supporting the movement of the cell body forward [<xref rid="B87-toxins-09-00390" ref-type="bibr">87</xref>]. Consistent with the essential role of the cytoskeleton in promoting cancer migration, its deregulation may cause anti-adhesive and anti-migratory effects. Two snake venom calcium-dependent (C-type) lectins alter the actin/cytoskeleton network in cancer cells. C-type lectins identified from snake venoms are classified in two groups: C-type glycan-binding lectins; and C-type lectin-like proteins, which do not interact with sugars. The C-type glycan-binding lectins are homodimeric non-enzymatic proteins that contain a carbohydrate recognition domain (CRD), binding mainly with galactose [<xref rid="B88-toxins-09-00390" ref-type="bibr">88</xref>].</p><p>Daboialectin, a low molecular weight C-type lectin isolated from <italic>Daboia russelii</italic> venom, produces morphological changes, including spindle-like shape with loss of cell&#x02013;cell contacts in lung cancer cells A549 [<xref rid="B89-toxins-09-00390" ref-type="bibr">89</xref>]. This snake toxin decreases the mRNA and protein levels of small GTPases Rho and Rac and increases the Cdc42 expression, which is in accordance with remarkable decrease of F-actin content, inhibition of migration and invasion observed in lung cancer cells treated with it [<xref rid="B89-toxins-09-00390" ref-type="bibr">89</xref>].</p><p>BJcuL is a C-type lectin from <italic>Bothrops jararacussu</italic> venom composed by a disulfide-linked dimer with high affinity for glycoproteins containing &#x003b2;-<sc>d</sc>-galactosides [<xref rid="B90-toxins-09-00390" ref-type="bibr">90</xref>]. BJcuL binds to cancer cells without affecting the adhesion of these cells to fibronectin, laminin, and type I collagen; however, it produces complete actin filament disorganization and disassembly in malignant cells [<xref rid="B91-toxins-09-00390" ref-type="bibr">91</xref>]. This toxin does not block the integrin signaling [<xref rid="B92-toxins-09-00390" ref-type="bibr">92</xref>], but it binds to cell surface with ECM glycoproteins, such as its substrate <sc>d</sc>-galactose, promoting the actin disassembles, an event that could accelerate cancer cell detachment from ECM, producing cell death [<xref rid="B91-toxins-09-00390" ref-type="bibr">91</xref>].</p></sec><sec id="sec6-toxins-09-00390"><title>6. Concluding Remarks</title><p>Given that malignant cells during metastasis exhibit molecular mechanisms different from those shown by non-metastatic and highly proliferative cancer cells, the conventional cytostatic drugs, which mainly target the cell proliferation, lack effects on the capacity to disseminate and grow in distant sites of metastatic cancer cells. This review highlights the need to search new anti-metastatic drugs. We identified three anti-metastatic mechanisms of action for at least six classes of toxins from snake venoms: (1) inhibition of ECM components-dependent adhesion and migration, (2) inhibition of EMT, and (3) inhibition of migration by alterations in the actin/cytoskeleton network.</p><p>These toxins may represent a natural source of molecular scaffolds to design new anti-migratory and anti-invasive agents by obtaining recombinant proteins or small molecules that act as antagonists of integrin signaling or inductors of actin disassembling by binding of cell surface glycoproteins. A selective inhibition of the signaling machinery involved in the cancer cell migration without affect those of migrating non-malignant cells is an important challenge for the new anti-metastatic drugs.</p><p>Interestingly, all anti-cancer evaluations on tumorigenic properties&#x02014;such as proliferation, angiogenesis, invasion, and metastasis of malignant cells&#x02014;have been performed with toxins isolated from front-fanged snake species, especially from <italic>Viperidae</italic> species; however, the potential therapeutic applications of toxins described from rear-fanged snake species&#x02014;e.g., [<xref rid="B28-toxins-09-00390" ref-type="bibr">28</xref>,<xref rid="B30-toxins-09-00390" ref-type="bibr">30</xref>,<xref rid="B31-toxins-09-00390" ref-type="bibr">31</xref>,<xref rid="B32-toxins-09-00390" ref-type="bibr">32</xref>,<xref rid="B93-toxins-09-00390" ref-type="bibr">93</xref>,<xref rid="B94-toxins-09-00390" ref-type="bibr">94</xref>,<xref rid="B95-toxins-09-00390" ref-type="bibr">95</xref>]&#x02014;remain unexplored.</p><p>An extensive development and conjugation of drug delivery systems with some snake toxins, which has reduced the toxicity and improved the selectivity toward cancer cells [<xref rid="B96-toxins-09-00390" ref-type="bibr">96</xref>,<xref rid="B97-toxins-09-00390" ref-type="bibr">97</xref>], highlight their promising applications as direct anti-cancer agents or potential tools for the development of novel therapeutic strategies [<xref rid="B16-toxins-09-00390" ref-type="bibr">16</xref>]. Finally, the in vivo validation of anti-metastatic effect described on in vitro cancer cell lines is a pending issue for drug discovery from snake toxins.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by FONDECYT grant #1140753 (R.A.-M.), Programa de Investigaci&#x000f3;n Asociativa en C&#x000e1;ncer G&#x000e1;strico (PIA-CG, RU2107) (R.A.-M.) and FONDECYT postdoctoral fellowship #3170813 (F.A.U.).</p></ack><notes><title>Author Contributions</title><p>F.A.U. and R.A.-M. designed and contributed to the literature review, discussion, and writing of the manuscript.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-toxins-09-00390"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gandalovi&#x0010d;ov&#x000e1;</surname><given-names>A.</given-names></name><name><surname>Rosel</surname><given-names>D.</given-names></name><name><surname>Fernandes</surname><given-names>M.</given-names></name><name><surname>Vesel&#x000fd;</surname><given-names>P.</given-names></name><name><surname>Heneberg</surname><given-names>P.</given-names></name><name><surname>&#x0010c;erm&#x000e1;k</surname><given-names>V.</given-names></name><name><surname>Petru&#x0017e;elka</surname><given-names>L.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Sanz-Moreno</surname><given-names>V.</given-names></name><name><surname>Br&#x000e1;bek</surname><given-names>J.</given-names></name></person-group><article-title>Migrastatics-Anti-metastatic and anti-invasion drugs: Promises and challenges</article-title><source>Trends Cancer</source><year>2017</year><volume>3</volume><fpage>391</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1016/j.trecan.2017.04.008</pub-id><?supplied-pmid 28670628?><pub-id pub-id-type="pmid">28670628</pub-id></element-citation></ref><ref id="B2-toxins-09-00390"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riggi</surname><given-names>N.</given-names></name><name><surname>Aguet</surname><given-names>M.</given-names></name><name><surname>Stamenkovic</surname><given-names>I.</given-names></name></person-group><article-title>Cancer metastasis: A reappraisal of its underlying mechanisms and their relevance to treatment</article-title><source>Annu. Rev. Pathol.</source><year>2017</year><pub-id pub-id-type="doi">10.1146/annurev-pathol-020117-044127</pub-id><?supplied-pmid 29068753?><pub-id pub-id-type="pmid">29068753</pub-id></element-citation></ref><ref id="B3-toxins-09-00390"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celi&#x000e0;-Terrassa</surname><given-names>T.</given-names></name><name><surname>Kang</surname><given-names>Y.</given-names></name></person-group><article-title>Distinctive properties of metastasis-initiating cells</article-title><source>Genes Dev.</source><year>2016</year><volume>30</volume><fpage>892</fpage><lpage>908</lpage><pub-id pub-id-type="doi">10.1101/gad.277681.116</pub-id><?supplied-pmid 27083997?><pub-id pub-id-type="pmid">27083997</pub-id></element-citation></ref><ref id="B4-toxins-09-00390"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomaskovic-Crook</surname><given-names>E.</given-names></name><name><surname>Thompson</surname><given-names>E.</given-names></name><name><surname>Thiery</surname><given-names>J.</given-names></name></person-group><article-title>Epithelial to mesenchymal transition and breast cancer</article-title><source>Breast Cancer Res.</source><year>2009</year><volume>11</volume><fpage>213</fpage><pub-id pub-id-type="doi">10.1186/bcr2416</pub-id><?supplied-pmid 19909494?><pub-id pub-id-type="pmid">19909494</pub-id></element-citation></ref><ref id="B5-toxins-09-00390"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamouille</surname><given-names>S.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Derynck</surname><given-names>R.</given-names></name></person-group><article-title>Molecular mechanisms of epithelial-mesenchymal transition</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2014</year><volume>15</volume><fpage>178</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1038/nrm3758</pub-id><?supplied-pmid 24556840?><pub-id pub-id-type="pmid">24556840</pub-id></element-citation></ref><ref id="B6-toxins-09-00390"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlsson</surname><given-names>M.</given-names></name><name><surname>Gonzalez</surname><given-names>S.</given-names></name><name><surname>Welin</surname><given-names>J.</given-names></name><name><surname>Fuxe</surname><given-names>J.</given-names></name></person-group><article-title>Epithelial-mesenchymal transition in cancer metastasis through the lymphatic system</article-title><source>Mol. Oncol.</source><year>2017</year><volume>11</volume><fpage>781</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.1002/1878-0261.12092</pub-id><?supplied-pmid 28590032?><pub-id pub-id-type="pmid">28590032</pub-id></element-citation></ref><ref id="B7-toxins-09-00390"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambert</surname><given-names>A.</given-names></name><name><surname>Pattabiraman</surname><given-names>D.</given-names></name><name><surname>Weinberg</surname><given-names>R.</given-names></name></person-group><article-title>Emerging biological principles of metastasis</article-title><source>Cell</source><year>2017</year><volume>168</volume><fpage>670</fpage><lpage>691</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.11.037</pub-id><?supplied-pmid 28187288?><pub-id pub-id-type="pmid">28187288</pub-id></element-citation></ref><ref id="B8-toxins-09-00390"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sleeman</surname><given-names>J.</given-names></name><name><surname>Steeg</surname><given-names>P.</given-names></name></person-group><article-title>Cancer metastasis as a therapeutic target</article-title><source>Eur. J. Cancer</source><year>2010</year><volume>46</volume><fpage>1177</fpage><lpage>1180</lpage><pub-id pub-id-type="doi">10.1016/j.ejca.2010.02.039</pub-id><?supplied-pmid 20307970?><pub-id pub-id-type="pmid">20307970</pub-id></element-citation></ref><ref id="B9-toxins-09-00390"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heath</surname><given-names>A.S.</given-names></name><name><surname>Yibin</surname><given-names>K.</given-names></name></person-group><article-title>Determinants of organotropic metastasis</article-title><source>Annu. Rev. Cancer Biol.</source><year>2017</year><volume>1</volume><fpage>403</fpage><lpage>423</lpage></element-citation></ref><ref id="B10-toxins-09-00390"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aranda-Souza</surname><given-names>M.</given-names></name><name><surname>Rossato</surname><given-names>F.</given-names></name><name><surname>Costa</surname><given-names>R.</given-names></name><name><surname>Figueira</surname><given-names>T.</given-names></name><name><surname>Castilho</surname><given-names>R.</given-names></name><name><surname>Guarniere</surname><given-names>M.</given-names></name><name><surname>Nunes</surname><given-names>E.</given-names></name><name><surname>Coelho</surname><given-names>L.</given-names></name><name><surname>Correia</surname><given-names>M.</given-names></name><name><surname>Vercesi</surname><given-names>A.</given-names></name></person-group><article-title>A lectin from Bothrops leucurus snake venom raises cytosolic calcium levels and promotes B16-F10 melanoma necrotic cell death via mitochondrial permeability transition</article-title><source>Toxicon</source><year>2014</year><volume>82</volume><fpage>97</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2014.02.018</pub-id><?supplied-pmid 24593964?><pub-id pub-id-type="pmid">24593964</pub-id></element-citation></ref><ref id="B11-toxins-09-00390"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebrahim</surname><given-names>K.</given-names></name><name><surname>Shirazi</surname><given-names>F.</given-names></name><name><surname>Mirakabadi</surname><given-names>A.</given-names></name><name><surname>Vatanpour</surname><given-names>H.</given-names></name></person-group><article-title>Cobra venom cytotoxins; apoptotic or necrotic agents?</article-title><source>Toxicon</source><year>2015</year><volume>108</volume><fpage>134</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2015.09.017</pub-id><?supplied-pmid 26482932?><pub-id pub-id-type="pmid">26482932</pub-id></element-citation></ref><ref id="B12-toxins-09-00390"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prinholato da Silva</surname><given-names>C.</given-names></name><name><surname>Costa</surname><given-names>T.</given-names></name><name><surname>Paiva</surname><given-names>R.</given-names></name><name><surname>Cintra</surname><given-names>A.</given-names></name><name><surname>Menaldo</surname><given-names>D.</given-names></name><name><surname>Antunes</surname><given-names>L.</given-names></name><name><surname>Sampaio</surname><given-names>S.</given-names></name></person-group><article-title>Antitumor potential of the myotoxin BthTX-I from Bothrops jararacussu snake venom: Evaluation of cell cycle alterations and death mechanisms induced in tumor cell lines</article-title><source>J. Venom. Anim. Toxins Incl. Trop. Dis.</source><year>2015</year><volume>21</volume><pub-id pub-id-type="doi">10.1186/s40409-015-0044-5</pub-id><?supplied-pmid 26539212?><pub-id pub-id-type="pmid">26539212</pub-id></element-citation></ref><ref id="B13-toxins-09-00390"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guimar&#x000e3;es</surname><given-names>D.</given-names></name><name><surname>Lopes</surname><given-names>D.</given-names></name><name><surname>Azevedo</surname><given-names>F.</given-names></name><name><surname>Gimenes</surname><given-names>S.</given-names></name><name><surname>Silva</surname><given-names>M.</given-names></name><name><surname>Ach&#x000ea;</surname><given-names>D.</given-names></name><name><surname>Gomes</surname><given-names>M.</given-names></name><name><surname>Vecchi</surname><given-names>L.</given-names></name><name><surname>Goulart</surname><given-names>L.</given-names></name><name><surname>Yoneyama</surname><given-names>K.</given-names></name><etal/></person-group><article-title>In vitro antitumor and antiangiogenic effects of Bothropoidin, a metalloproteinase from <italic>Bothrops pauloensis</italic> snake venom</article-title><source>Int. J. Biol. Macromol.</source><year>2017</year><volume>97</volume><fpage>770</fpage><lpage>777</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2017.01.064</pub-id><?supplied-pmid 28093334?><pub-id pub-id-type="pmid">28093334</pub-id></element-citation></ref><ref id="B14-toxins-09-00390"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhananjaya</surname><given-names>B.</given-names></name><name><surname>Sivashankari</surname><given-names>P.</given-names></name></person-group><article-title>Snake venom derived molecules in tumor angiogenesis and its application in cancer therapy; an overview</article-title><source>Curr. Top. Med. Chem.</source><year>2015</year><volume>15</volume><fpage>649</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.2174/1568026615666150225113402</pub-id><?supplied-pmid 25714377?><pub-id pub-id-type="pmid">25714377</pub-id></element-citation></ref><ref id="B15-toxins-09-00390"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azevedo</surname><given-names>F.</given-names></name><name><surname>Lopes</surname><given-names>D.</given-names></name><name><surname>Cirilo-Gimenes</surname><given-names>S.</given-names></name><name><surname>Ach&#x000ea;</surname><given-names>D.</given-names></name><name><surname>Vecchi</surname><given-names>L.</given-names></name><name><surname>Alves</surname><given-names>P.</given-names></name><name><surname>de Oliveira Guimar&#x000e3;es</surname><given-names>D.</given-names></name><name><surname>Rodrigues</surname><given-names>R.</given-names></name><name><surname>Goulart</surname><given-names>L.</given-names></name><name><surname>de Melo Rodrigues</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Human breast cancer cell death induced by BnSP-6, a Lys-49 PLA homologue from <italic>Bothrops pauloensis</italic> venom</article-title><source>Int. J. Biol. Macromol.</source><year>2016</year><volume>82</volume><fpage>671</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2015.10.080</pub-id><?supplied-pmid 26519876?><pub-id pub-id-type="pmid">26519876</pub-id></element-citation></ref><ref id="B16-toxins-09-00390"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>T.</given-names></name><name><surname>Menaldo</surname><given-names>D.</given-names></name><name><surname>Zoccal</surname><given-names>K.</given-names></name><name><surname>Burin</surname><given-names>S.</given-names></name><name><surname>Aissa</surname><given-names>A.</given-names></name><name><surname>Castro</surname><given-names>F.</given-names></name><name><surname>Faccioli</surname><given-names>L.</given-names></name><name><surname>Greggi-Antunes</surname><given-names>L.</given-names></name><name><surname>Sampaio</surname><given-names>S.</given-names></name></person-group><article-title>CR-LAAO, an <sc>l</sc>-amino acid oxidase from <italic>Calloselasma rhodostoma</italic> venom, as a potential tool for developing novel immunotherapeutic strategies against cancer</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>42673</fpage><pub-id pub-id-type="doi">10.1038/srep42673</pub-id><?supplied-pmid 28205610?><pub-id pub-id-type="pmid">28205610</pub-id></element-citation></ref><ref id="B17-toxins-09-00390"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartsch</surname><given-names>J.</given-names></name><name><surname>Staren</surname><given-names>E.</given-names></name><name><surname>Appert</surname><given-names>H.</given-names></name></person-group><article-title>Adhesion and migration of extracellular matrix-stimulated breast cancer</article-title><source>J. Surg. Res.</source><year>2003</year><volume>110</volume><fpage>287</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1016/S0022-4804(03)00004-0</pub-id><pub-id pub-id-type="pmid">12697413</pub-id></element-citation></ref><ref id="B18-toxins-09-00390"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>L.</given-names></name><name><surname>Owens</surname><given-names>T.</given-names></name><name><surname>Naylor</surname><given-names>M.</given-names></name></person-group><article-title>Structural and mechanical functions of integrins</article-title><source>Biophys. Rev.</source><year>2014</year><volume>6</volume><fpage>203</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1007/s12551-013-0124-0</pub-id><?supplied-pmid 28510180?><pub-id pub-id-type="pmid">28510180</pub-id></element-citation></ref><ref id="B19-toxins-09-00390"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longmate</surname><given-names>W.</given-names></name><name><surname>DiPersio</surname><given-names>C.</given-names></name></person-group><article-title>Beyond adhesion: Emerging roles for integrins in control of the tumor microenvironment</article-title><source>F1000Research</source><year>2017</year><volume>6</volume><pub-id pub-id-type="doi">10.12688/f1000research.11877.1</pub-id><?supplied-pmid 29026524?><pub-id pub-id-type="pmid">29026524</pub-id></element-citation></ref><ref id="B20-toxins-09-00390"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwakwa</surname><given-names>K.</given-names></name><name><surname>Sterling</surname><given-names>J.</given-names></name></person-group><article-title>Integrin &#x003b1;v&#x003b2;3 signaling in tumor-induced bone disease</article-title><source>Cancers (Basel)</source><year>2017</year><volume>9</volume><elocation-id>84</elocation-id><pub-id pub-id-type="doi">10.3390/cancers9070084</pub-id><?supplied-pmid 28698458?><pub-id pub-id-type="pmid">28698458</pub-id></element-citation></ref><ref id="B21-toxins-09-00390"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name></person-group><article-title>The roles of integrin &#x003b1;v&#x003b2;6 in cancer</article-title><source>Cancer Lett.</source><year>2017</year><volume>403</volume><fpage>128</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2017.06.012</pub-id><?supplied-pmid 28634043?><pub-id pub-id-type="pmid">28634043</pub-id></element-citation></ref><ref id="B22-toxins-09-00390"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rathinam</surname><given-names>R.</given-names></name><name><surname>Alahari</surname><given-names>S.</given-names></name></person-group><article-title>Important role of integrins in the cancer biology</article-title><source>Cancer Metastasis Rev.</source><year>2010</year><volume>29</volume><fpage>223</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1007/s10555-010-9211-x</pub-id><?supplied-pmid 20112053?><pub-id pub-id-type="pmid">20112053</pub-id></element-citation></ref><ref id="B23-toxins-09-00390"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marelli</surname><given-names>U.</given-names></name><name><surname>Rechenmacher</surname><given-names>F.</given-names></name><name><surname>Sobahi</surname><given-names>T.</given-names></name><name><surname>Mas-Moruno</surname><given-names>C.</given-names></name><name><surname>Kessler</surname><given-names>H.</given-names></name></person-group><article-title>Tumor Targeting via Integrin Ligands</article-title><source>Front. Oncol.</source><year>2013</year><volume>3</volume><fpage>222</fpage><pub-id pub-id-type="doi">10.3389/fonc.2013.00222</pub-id><?supplied-pmid 24010121?><pub-id pub-id-type="pmid">24010121</pub-id></element-citation></ref><ref id="B24-toxins-09-00390"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapp</surname><given-names>T.</given-names></name><name><surname>Rechenmacher</surname><given-names>F.</given-names></name><name><surname>Neubauer</surname><given-names>S.</given-names></name><name><surname>Maltsev</surname><given-names>O.</given-names></name><name><surname>Cavalcanti-Adam</surname><given-names>E.</given-names></name><name><surname>Zarka</surname><given-names>R.</given-names></name><name><surname>Reuning</surname><given-names>U.</given-names></name><name><surname>Notni</surname><given-names>J.</given-names></name><name><surname>Wester</surname><given-names>H.</given-names></name><name><surname>Mas-Moruno</surname><given-names>C.</given-names></name><etal/></person-group><article-title>A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>39805</fpage><pub-id pub-id-type="doi">10.1038/srep39805</pub-id><?supplied-pmid 28074920?><pub-id pub-id-type="pmid">28074920</pub-id></element-citation></ref><ref id="B25-toxins-09-00390"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moura-da-Silva</surname><given-names>A.</given-names></name><name><surname>Theakston</surname><given-names>R.</given-names></name><name><surname>Crampton</surname><given-names>J.</given-names></name></person-group><article-title>Evolution of disintegrin cysteine-rich and mammalian matrix-degrading metalloproteinases: Gene duplication and divergence of a common ancestor rather than convergent evolution</article-title><source>J. Mol. Evol.</source><year>1996</year><volume>43</volume><fpage>263</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1007/BF02338834</pub-id><?supplied-pmid 8703092?><pub-id pub-id-type="pmid">8703092</pub-id></element-citation></ref><ref id="B26-toxins-09-00390"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calvete</surname><given-names>J.</given-names></name><name><surname>Marcinkiewicz</surname><given-names>C.</given-names></name><name><surname>Monle&#x000f3;n</surname><given-names>D.</given-names></name><name><surname>Esteve</surname><given-names>V.</given-names></name><name><surname>Celda</surname><given-names>B.</given-names></name><name><surname>Ju&#x000e1;rez</surname><given-names>P.</given-names></name><name><surname>Sanz</surname><given-names>L.</given-names></name></person-group><article-title>Snake venom disintegrins: Evolution of structure and function</article-title><source>Toxicon</source><year>2005</year><volume>45</volume><fpage>1063</fpage><lpage>1074</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2005.02.024</pub-id><?supplied-pmid 15922775?><pub-id pub-id-type="pmid">15922775</pub-id></element-citation></ref><ref id="B27-toxins-09-00390"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeda</surname><given-names>S.</given-names></name><name><surname>Takeya</surname><given-names>H.</given-names></name><name><surname>Iwanaga</surname><given-names>S.</given-names></name></person-group><article-title>Snake venom metalloproteinases: Structure, function and relevance to the mammalian ADAM/ADAMTS family proteins</article-title><source>Biochim. Biophys. Acta</source><year>2012</year><volume>1824</volume><fpage>164</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1016/j.bbapap.2011.04.009</pub-id><?supplied-pmid 21530690?><pub-id pub-id-type="pmid">21530690</pub-id></element-citation></ref><ref id="B28-toxins-09-00390"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weldon</surname><given-names>C.</given-names></name><name><surname>Mackessy</surname><given-names>S.</given-names></name></person-group><article-title>Alsophinase, a new P-III metalloproteinase with &#x003b1;-fibrinogenolytic and hemorrhagic activity from the venom of the rear-fanged Puerto Rican Racer <italic>Alsophis portoricensis</italic> (Serpentes: Dipsadidae)</article-title><source>Biochimie</source><year>2012</year><volume>94</volume><fpage>1189</fpage><lpage>1198</lpage><pub-id pub-id-type="doi">10.1016/j.biochi.2012.02.006</pub-id><?supplied-pmid 22349739?><pub-id pub-id-type="pmid">22349739</pub-id></element-citation></ref><ref id="B29-toxins-09-00390"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peichoto</surname><given-names>M.E.</given-names></name><name><surname>Paes Leme</surname><given-names>A.F.</given-names></name><name><surname>Pauletti</surname><given-names>B.A.</given-names></name><name><surname>Batista</surname><given-names>I.C.</given-names></name><name><surname>Mackessy</surname><given-names>S.P.</given-names></name><name><surname>Acosta</surname><given-names>O.</given-names></name><name><surname>Santoro</surname><given-names>M.L.</given-names></name></person-group><article-title>Autolysis at the disintegrin domain of patagonfibrase, a metalloproteinase from <italic>Philodryas patagoniensis</italic> (Patagonia Green Racer; Dipsadidae) venom</article-title><source>BBA Proteins Proteom.</source><year>2010</year><volume>1804</volume><fpage>1937</fpage><lpage>1942</lpage><pub-id pub-id-type="doi">10.1016/j.bbapap.2010.06.005</pub-id><?supplied-pmid 20538077?><pub-id pub-id-type="pmid">20538077</pub-id></element-citation></ref><ref id="B30-toxins-09-00390"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ching</surname><given-names>A.T.</given-names></name><name><surname>Paes Leme</surname><given-names>A.F.</given-names></name><name><surname>Zelanis</surname><given-names>A.</given-names></name><name><surname>Rocha</surname><given-names>M.M.</given-names></name><name><surname>Furtado</surname><given-names>M.D.F.</given-names></name><name><surname>Silva</surname><given-names>D.A.</given-names></name><name><surname>Trugilho</surname><given-names>M.R.</given-names></name><name><surname>da Rocha</surname><given-names>S.L.</given-names></name><name><surname>Perales</surname><given-names>J.</given-names></name><name><surname>Ho</surname><given-names>P.L.</given-names></name><etal/></person-group><article-title>Venomics profiling of <italic>Thamnodynastes strigatus</italic> unveils matrix metalloproteinases and other novel proteins recruited to the toxin arsenal of rear-fanged snakes</article-title><source>J. Proteome Res.</source><year>2012</year><volume>11</volume><fpage>1152</fpage><lpage>1162</lpage><pub-id pub-id-type="doi">10.1021/pr200876c</pub-id><?supplied-pmid 22168127?><pub-id pub-id-type="pmid">22168127</pub-id></element-citation></ref><ref id="B31-toxins-09-00390"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ching</surname><given-names>A.T.</given-names></name><name><surname>Rocha</surname><given-names>M.M.</given-names></name><name><surname>Paes Leme</surname><given-names>A.F.</given-names></name><name><surname>Pimenta</surname><given-names>D.C.</given-names></name><name><surname>de Fatima</surname><given-names>D.F.M.</given-names></name><name><surname>Serrano</surname><given-names>S.M.</given-names></name><name><surname>Ho</surname><given-names>P.L.</given-names></name><name><surname>Junqueira-de-Azevedo</surname><given-names>I.L.</given-names></name></person-group><article-title>Some aspects of the venom proteome of the Colubridae snake <italic>Philodryas olfersii</italic> revealed from a Duvernoy&#x02019;s (venom) gland transcriptome</article-title><source>FEBS Lett.</source><year>2006</year><volume>580</volume><fpage>4417</fpage><lpage>4422</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2006.07.010</pub-id><?supplied-pmid 16857193?><pub-id pub-id-type="pmid">16857193</pub-id></element-citation></ref><ref id="B32-toxins-09-00390"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urra</surname><given-names>F.</given-names></name><name><surname>Pulgar</surname><given-names>R.</given-names></name><name><surname>Guti&#x000e9;rrez</surname><given-names>R.</given-names></name><name><surname>Hodar</surname><given-names>C.</given-names></name><name><surname>Cambiazo</surname><given-names>V.</given-names></name><name><surname>Labra</surname><given-names>A.</given-names></name></person-group><article-title>Identification and molecular characterization of five putative toxins from the venom gland of the snake Philodryas chamissonis (Serpentes: Dipsadidae)</article-title><source>Toxicon</source><year>2015</year><volume>108</volume><fpage>19</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2015.09.032</pub-id><?supplied-pmid 26410112?><pub-id pub-id-type="pmid">26410112</pub-id></element-citation></ref><ref id="B33-toxins-09-00390"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamiguti</surname><given-names>A.</given-names></name><name><surname>Theakston</surname><given-names>R.</given-names></name><name><surname>Sherman</surname><given-names>N.</given-names></name><name><surname>Fox</surname><given-names>J.</given-names></name></person-group><article-title>Mass spectrophotometric evidence for P-III/P-IV metalloproteinases in the venom of the Boomslang (<italic>Dispholidus typus</italic>)</article-title><source>Toxicon</source><year>2000</year><volume>38</volume><fpage>1613</fpage><lpage>1620</lpage><pub-id pub-id-type="doi">10.1016/S0041-0101(00)00089-1</pub-id><pub-id pub-id-type="pmid">10775761</pub-id></element-citation></ref><ref id="B34-toxins-09-00390"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Hu</surname><given-names>T.</given-names></name><name><surname>Zhou</surname><given-names>W.</given-names></name><name><surname>Cui</surname><given-names>Q.</given-names></name><name><surname>Tian</surname><given-names>J.</given-names></name><name><surname>Zheng</surname><given-names>Y.</given-names></name><name><surname>Fan</surname><given-names>Q.</given-names></name></person-group><article-title>Discovery of toxin-encoding genes from the false viper <italic>Macropisthodon rudis</italic>, a rear-fanged snake, by transcriptome analysis of venom gland</article-title><source>Toxicon</source><year>2015</year><volume>106</volume><fpage>72</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2015.09.021</pub-id><?supplied-pmid 26403866?><pub-id pub-id-type="pmid">26403866</pub-id></element-citation></ref><ref id="B35-toxins-09-00390"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGivern</surname><given-names>J.</given-names></name><name><surname>Wray</surname><given-names>K.</given-names></name><name><surname>Margres</surname><given-names>M.</given-names></name><name><surname>Couch</surname><given-names>M.</given-names></name><name><surname>Mackessy</surname><given-names>S.</given-names></name><name><surname>Rokyta</surname><given-names>D.</given-names></name></person-group><article-title>RNA-seq and high-definition mass spectrometry reveal the complex and divergent venoms of two rear-fanged colubrid snakes</article-title><source>BMC Genom.</source><year>2014</year><volume>15</volume><elocation-id>1061</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2164-15-1061</pub-id><?supplied-pmid 25476704?><pub-id pub-id-type="pmid">25476704</pub-id></element-citation></ref><ref id="B36-toxins-09-00390"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname><given-names>E.</given-names></name><name><surname>Marcinkiewicz</surname><given-names>C.</given-names></name></person-group><article-title>Non-RGD-containing snake venom disintegrins, functional and structural relations</article-title><source>Toxicon</source><year>2011</year><volume>58</volume><fpage>355</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2011.07.004</pub-id><?supplied-pmid 21801741?><pub-id pub-id-type="pmid">21801741</pub-id></element-citation></ref><ref id="B37-toxins-09-00390"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calvete</surname><given-names>J.</given-names></name></person-group><article-title>The continuing saga of snake venom disintegrins</article-title><source>Toxicon</source><year>2013</year><volume>62</volume><fpage>40</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2012.09.005</pub-id><?supplied-pmid 23010163?><pub-id pub-id-type="pmid">23010163</pub-id></element-citation></ref><ref id="B38-toxins-09-00390"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeda</surname><given-names>S.</given-names></name></person-group><article-title>ADAM and ADAMTS family proteins and snake venom metalloproteinases: A structural overview</article-title><source>Toxins (Basel)</source><year>2016</year><volume>8</volume><elocation-id>E155</elocation-id><pub-id pub-id-type="doi">10.3390/toxins8050155</pub-id><?supplied-pmid 27196928?><pub-id pub-id-type="pmid">27196928</pub-id></element-citation></ref><ref id="B39-toxins-09-00390"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saviola</surname><given-names>A.</given-names></name><name><surname>Modahl</surname><given-names>C.</given-names></name><name><surname>Mackessy</surname><given-names>S.</given-names></name></person-group><article-title>Disintegrins of <italic>Crotalus simus</italic> tzabcan venom: Isolation, characterization and evaluation of the cytotoxic and anti-adhesion activities of tzabcanin, a new RGD disintegrin</article-title><source>Biochimie</source><year>2015</year><volume>116</volume><fpage>92</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.biochi.2015.07.005</pub-id><?supplied-pmid 26163300?><pub-id pub-id-type="pmid">26163300</pub-id></element-citation></ref><ref id="B40-toxins-09-00390"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saviola</surname><given-names>A.</given-names></name><name><surname>Burns</surname><given-names>P.</given-names></name><name><surname>Mukherjee</surname><given-names>A.</given-names></name><name><surname>Mackessy</surname><given-names>S.</given-names></name></person-group><article-title>The disintegrin tzabcanin inhibits adhesion and migration in melanoma and lung cancer cells</article-title><source>Int. J. Biol. Macromol.</source><year>2016</year><volume>88</volume><fpage>457</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2016.04.008</pub-id><?supplied-pmid 27060015?><pub-id pub-id-type="pmid">27060015</pub-id></element-citation></ref><ref id="B41-toxins-09-00390"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suntravat</surname><given-names>M.</given-names></name><name><surname>Barret</surname><given-names>H.</given-names></name><name><surname>Jurica</surname><given-names>C.</given-names></name><name><surname>Lucena</surname><given-names>S.</given-names></name><name><surname>Perez</surname><given-names>J.</given-names></name><name><surname>S&#x000e1;nchez</surname><given-names>E.</given-names></name></person-group><article-title>Recombinant disintegrin (r-Cam-dis) from Crotalus adamanteus inhibits adhesion of human pancreatic cancer cell lines to laminin-1 and vitronectin</article-title><source>J. Venom Res.</source><year>2015</year><volume>6</volume><fpage>1</fpage><lpage>10</lpage><?supplied-pmid 26045944?><pub-id pub-id-type="pmid">26045944</pub-id></element-citation></ref><ref id="B42-toxins-09-00390"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suntravat</surname><given-names>M.</given-names></name><name><surname>Helmke</surname><given-names>T.</given-names></name><name><surname>Atphaisit</surname><given-names>C.</given-names></name><name><surname>Cuevas</surname><given-names>E.</given-names></name><name><surname>Lucena</surname><given-names>S.</given-names></name><name><surname>Uzc&#x000e1;tegui</surname><given-names>N.</given-names></name><name><surname>S&#x000e1;nchez</surname><given-names>E.</given-names></name><name><surname>Rodriguez-Acosta</surname><given-names>A.</given-names></name></person-group><article-title>Expression, purification, and analysis of three recombinant ECD disintegrins (r-colombistatins) from P-III class snake venom metalloproteinases affecting platelet aggregation and SK-MEL-28 cell adhesion</article-title><source>Toxicon</source><year>2016</year><volume>122</volume><fpage>43</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2016.09.007</pub-id><?supplied-pmid 27641750?><pub-id pub-id-type="pmid">27641750</pub-id></element-citation></ref><ref id="B43-toxins-09-00390"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montenegro</surname><given-names>C.</given-names></name><name><surname>Casali</surname><given-names>B.</given-names></name><name><surname>Lino</surname><given-names>R.</given-names></name><name><surname>Pachane</surname><given-names>B.</given-names></name><name><surname>Santos</surname><given-names>P.</given-names></name><name><surname>Horwitz</surname><given-names>A.</given-names></name><name><surname>Selistre-de-Araujo</surname><given-names>H.</given-names></name><name><surname>Lamers</surname><given-names>M.</given-names></name></person-group><article-title>Inhibition of &#x003b1;v&#x003b2;3 integrin induces loss of cell directionality of oral squamous carcinoma cells (OSCC)</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><elocation-id>e0176226</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0176226</pub-id><?supplied-pmid 28437464?><pub-id pub-id-type="pmid">28437464</pub-id></element-citation></ref><ref id="B44-toxins-09-00390"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucena</surname><given-names>S.</given-names></name><name><surname>Castro</surname><given-names>R.</given-names></name><name><surname>Lundin</surname><given-names>C.</given-names></name><name><surname>Hofstetter</surname><given-names>A.</given-names></name><name><surname>Alaniz</surname><given-names>A.</given-names></name><name><surname>Suntravat</surname><given-names>M.</given-names></name><name><surname>S&#x000e1;nchez</surname><given-names>E.</given-names></name></person-group><article-title>Inhibition of pancreatic tumoral cells by snake venom disintegrins</article-title><source>Toxicon</source><year>2015</year><volume>93</volume><fpage>136</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2014.11.228</pub-id><?supplied-pmid 25450798?><pub-id pub-id-type="pmid">25450798</pub-id></element-citation></ref><ref id="B45-toxins-09-00390"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucena</surname><given-names>S.</given-names></name><name><surname>Sanchez</surname><given-names>E.</given-names></name><name><surname>Perez</surname><given-names>J.</given-names></name></person-group><article-title>Anti-metastatic activity of the recombinant disintegrin, r-mojastin 1, from the Mohave rattlesnake</article-title><source>Toxicon</source><year>2011</year><volume>57</volume><fpage>794</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2011.02.014</pub-id><?supplied-pmid 21334359?><pub-id pub-id-type="pmid">21334359</pub-id></element-citation></ref><ref id="B46-toxins-09-00390"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucena</surname><given-names>S.</given-names></name><name><surname>Jia</surname><given-names>Y.</given-names></name><name><surname>Soto</surname><given-names>J.</given-names></name><name><surname>Parral</surname><given-names>J.</given-names></name><name><surname>Cantu</surname><given-names>E.</given-names></name><name><surname>Brannon</surname><given-names>J.</given-names></name><name><surname>Lardner</surname><given-names>K.</given-names></name><name><surname>Ramos</surname><given-names>C.</given-names></name><name><surname>Seoane</surname><given-names>A.</given-names></name><name><surname>S&#x000e1;nchez</surname><given-names>E.</given-names></name></person-group><article-title>Anti-invasive and anti-adhesive activities of a recombinant disintegrin, r-viridistatin 2, derived from the Prairie rattlesnake (<italic>Crotalus viridis viridis</italic>)</article-title><source>Toxicon</source><year>2012</year><volume>60</volume><fpage>31</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2012.03.011</pub-id><?supplied-pmid 22465495?><pub-id pub-id-type="pmid">22465495</pub-id></element-citation></ref><ref id="B47-toxins-09-00390"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jebali</surname><given-names>J.</given-names></name><name><surname>Fakhfekh</surname><given-names>E.</given-names></name><name><surname>Morgen</surname><given-names>M.</given-names></name><name><surname>Srairi-Abid</surname><given-names>N.</given-names></name><name><surname>Majdoub</surname><given-names>H.</given-names></name><name><surname>Gargouri</surname><given-names>A.</given-names></name><name><surname>El Ayeb</surname><given-names>M.</given-names></name><name><surname>Luis</surname><given-names>J.</given-names></name><name><surname>Marrakchi</surname><given-names>N.</given-names></name><name><surname>Sarray</surname><given-names>S.</given-names></name></person-group><article-title>Lebecin, a new C-type lectin like protein from <italic>Macrovipera lebetina</italic> venom with anti-tumor activity against the breast cancer cell line MDA-MB231</article-title><source>Toxicon</source><year>2014</year><volume>86</volume><fpage>16</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2014.04.010</pub-id><?supplied-pmid 24814013?><pub-id pub-id-type="pmid">24814013</pub-id></element-citation></ref><ref id="B48-toxins-09-00390"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morjen</surname><given-names>M.</given-names></name><name><surname>Kallech-Ziri</surname><given-names>O.</given-names></name><name><surname>Bazaa</surname><given-names>A.</given-names></name><name><surname>Othman</surname><given-names>H.</given-names></name><name><surname>Mabrouk</surname><given-names>K.</given-names></name><name><surname>Zouari-Kessentini</surname><given-names>R.</given-names></name><name><surname>Sanz</surname><given-names>L.</given-names></name><name><surname>Calvete</surname><given-names>J.</given-names></name><name><surname>Srairi-Abid</surname><given-names>N.</given-names></name><name><surname>El Ayeb</surname><given-names>M.</given-names></name><etal/></person-group><article-title>PIVL, a new serine protease inhibitor from <italic>Macrovipera lebetina transmediterranea</italic> venom, impairs motility of human glioblastoma cells</article-title><source>Matrix Biol.</source><year>2013</year><volume>32</volume><fpage>52</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.matbio.2012.11.015</pub-id><?supplied-pmid 23262217?><pub-id pub-id-type="pmid">23262217</pub-id></element-citation></ref><ref id="B49-toxins-09-00390"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramos</surname><given-names>O.</given-names></name><name><surname>Kauskot</surname><given-names>A.</given-names></name><name><surname>Cominetti</surname><given-names>M.</given-names></name><name><surname>Bechyne</surname><given-names>I.</given-names></name><name><surname>Salla-Pontes</surname><given-names>C.</given-names></name><name><surname>Chareyre</surname><given-names>F.</given-names></name><name><surname>Manent</surname><given-names>J.</given-names></name><name><surname>Vassy</surname><given-names>R.</given-names></name><name><surname>Giovannini</surname><given-names>M.</given-names></name><name><surname>Legrand</surname><given-names>C.</given-names></name><etal/></person-group><article-title>A novel alpha(v)beta (3)-blocking disintegrin containing the RGD motive, DisBa-01, inhibits bFGF-induced angiogenesis and melanoma metastasis</article-title><source>Clin. Exp. Metastasis</source><year>2008</year><volume>25</volume><fpage>53</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1007/s10585-007-9101-y</pub-id><?supplied-pmid 17952617?><pub-id pub-id-type="pmid">17952617</pub-id></element-citation></ref><ref id="B50-toxins-09-00390"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selistre-de-Araujo</surname><given-names>H.</given-names></name><name><surname>Pontes</surname><given-names>C.</given-names></name><name><surname>Montenegro</surname><given-names>C.</given-names></name><name><surname>Martin</surname><given-names>A.</given-names></name></person-group><article-title>Snake venom disintegrins and cell migration</article-title><source>Toxins (Basel)</source><year>2010</year><volume>2</volume><fpage>2606</fpage><lpage>2621</lpage><pub-id pub-id-type="doi">10.3390/toxins2112606</pub-id><?supplied-pmid 22069567?><pub-id pub-id-type="pmid">22069567</pub-id></element-citation></ref><ref id="B51-toxins-09-00390"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarray</surname><given-names>S.</given-names></name><name><surname>Berthet</surname><given-names>V.</given-names></name><name><surname>Calvete</surname><given-names>J.</given-names></name><name><surname>Secchi</surname><given-names>J.</given-names></name><name><surname>Marvaldi</surname><given-names>J.</given-names></name><name><surname>El-Ayeb</surname><given-names>M.</given-names></name><name><surname>Marrakchi</surname><given-names>N.</given-names></name><name><surname>Luis</surname><given-names>J.</given-names></name></person-group><article-title>Lebectin, a novel C-type lectin from <italic>Macrovipera lebetina</italic> venom, inhibits integrin-mediated adhesion, migration and invasion of human tumour cells</article-title><source>Lab. Investig.</source><year>2004</year><volume>84</volume><fpage>573</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1038/labinvest.3700088</pub-id><?supplied-pmid 15048137?><pub-id pub-id-type="pmid">15048137</pub-id></element-citation></ref><ref id="B52-toxins-09-00390"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarray</surname><given-names>S.</given-names></name><name><surname>Delamarre</surname><given-names>E.</given-names></name><name><surname>Marvaldi</surname><given-names>J.</given-names></name><name><surname>El Ayeb</surname><given-names>M.</given-names></name><name><surname>Marrakchi</surname><given-names>N.</given-names></name><name><surname>Luis</surname><given-names>J.</given-names></name></person-group><article-title>Lebectin and lebecetin, two C-type lectins from snake venom, inhibit alpha5beta1 and alphaV-containing integrins</article-title><source>Matrix Biol.</source><year>2007</year><volume>26</volume><fpage>306</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1016/j.matbio.2007.01.001</pub-id><?supplied-pmid 17300927?><pub-id pub-id-type="pmid">17300927</pub-id></element-citation></ref><ref id="B53-toxins-09-00390"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morjen</surname><given-names>M.</given-names></name><name><surname>Honor&#x000e9;</surname><given-names>S.</given-names></name><name><surname>Bazaa</surname><given-names>A.</given-names></name><name><surname>Abdelkafi-Koubaa</surname><given-names>Z.</given-names></name><name><surname>Ellafi</surname><given-names>A.</given-names></name><name><surname>Mabrouk</surname><given-names>K.</given-names></name><name><surname>Kovacic</surname><given-names>H.</given-names></name><name><surname>El Ayeb</surname><given-names>M.</given-names></name><name><surname>Marrakchi</surname><given-names>N.</given-names></name><name><surname>Luis</surname><given-names>J.</given-names></name></person-group><article-title>PIVL, a snake venom Kunitz-type serine protease inhibitor, inhibits in vitro and in vivo angiogenesis</article-title><source>Microvasc. Res.</source><year>2014</year><volume>95</volume><fpage>149</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1016/j.mvr.2014.08.006</pub-id><?supplied-pmid 25173589?><pub-id pub-id-type="pmid">25173589</pub-id></element-citation></ref><ref id="B54-toxins-09-00390"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ansieau</surname><given-names>S.</given-names></name><name><surname>Bastid</surname><given-names>J.</given-names></name><name><surname>Doreau</surname><given-names>A.</given-names></name><name><surname>Morel</surname><given-names>A.</given-names></name><name><surname>Bouchet</surname><given-names>B.</given-names></name><name><surname>Thomas</surname><given-names>C.</given-names></name><name><surname>Fauvet</surname><given-names>F.</given-names></name><name><surname>Puisieux</surname><given-names>I.</given-names></name><name><surname>Doglioni</surname><given-names>C.</given-names></name><name><surname>Piccinin</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence</article-title><source>Cancer Cell</source><year>2008</year><volume>14</volume><fpage>79</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2008.06.005</pub-id><?supplied-pmid 18598946?><pub-id pub-id-type="pmid">18598946</pub-id></element-citation></ref><ref id="B55-toxins-09-00390"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>K.</given-names></name><name><surname>Durrans</surname><given-names>A.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Sheng</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Wong</surname><given-names>S.</given-names></name><name><surname>Choi</surname><given-names>H.</given-names></name><name><surname>El Rayes</surname><given-names>T.</given-names></name><name><surname>Ryu</surname><given-names>S.</given-names></name><name><surname>Troeger</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance</article-title><source>Nature</source><year>2015</year><volume>527</volume><fpage>472</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.1038/nature15748</pub-id><?supplied-pmid 26560033?><pub-id pub-id-type="pmid">26560033</pub-id></element-citation></ref><ref id="B56-toxins-09-00390"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kajiyama</surname><given-names>H.</given-names></name><name><surname>Shibata</surname><given-names>K.</given-names></name><name><surname>Terauchi</surname><given-names>M.</given-names></name><name><surname>Yamashita</surname><given-names>M.</given-names></name><name><surname>Ino</surname><given-names>K.</given-names></name><name><surname>Nawa</surname><given-names>A.</given-names></name><name><surname>Kikkawa</surname><given-names>F.</given-names></name></person-group><article-title>Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells</article-title><source>Int. J. Oncol.</source><year>2007</year><volume>31</volume><fpage>277</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.3892/ijo.31.2.277</pub-id><?supplied-pmid 17611683?><pub-id pub-id-type="pmid">17611683</pub-id></element-citation></ref><ref id="B57-toxins-09-00390"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shibue</surname><given-names>T.</given-names></name><name><surname>Weinberg</surname><given-names>R.</given-names></name></person-group><article-title>EMT, CSCs, and drug resistance: The mechanistic link and clinical implications</article-title><source>Nat. Rev. Clin. Oncol.</source><year>2017</year><volume>14</volume><fpage>611</fpage><lpage>629</lpage><pub-id pub-id-type="doi">10.1038/nrclinonc.2017.44</pub-id><?supplied-pmid 28397828?><pub-id pub-id-type="pmid">28397828</pub-id></element-citation></ref><ref id="B58-toxins-09-00390"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulholland</surname><given-names>D.</given-names></name><name><surname>Kobayashi</surname><given-names>N.</given-names></name><name><surname>Ruscetti</surname><given-names>M.</given-names></name><name><surname>Zhi</surname><given-names>A.</given-names></name><name><surname>Tran</surname><given-names>L.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Gleave</surname><given-names>M.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name></person-group><article-title>Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells</article-title><source>Cancer Res.</source><year>2012</year><volume>72</volume><fpage>1878</fpage><lpage>1889</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-11-3132</pub-id><?supplied-pmid 22350410?><pub-id pub-id-type="pmid">22350410</pub-id></element-citation></ref><ref id="B59-toxins-09-00390"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bo</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Gao</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Chang</surname><given-names>X.</given-names></name><name><surname>Zhu</surname><given-names>M.</given-names></name></person-group><article-title>Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells</article-title><source>BMC Cancer</source><year>2013</year><volume>13</volume><elocation-id>496</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2407-13-496</pub-id><?supplied-pmid 24156409?><pub-id pub-id-type="pmid">24156409</pub-id></element-citation></ref><ref id="B60-toxins-09-00390"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foroni</surname><given-names>C.</given-names></name><name><surname>Broggini</surname><given-names>M.</given-names></name><name><surname>Generali</surname><given-names>D.</given-names></name><name><surname>Damia</surname><given-names>G.</given-names></name></person-group><article-title>Epithelial-mesenchymal transition and breast cancer: Role, molecular mechanisms and clinical impact</article-title><source>Cancer Treat. Rev.</source><year>2012</year><volume>38</volume><fpage>689</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1016/j.ctrv.2011.11.001</pub-id><?supplied-pmid 22118888?><pub-id pub-id-type="pmid">22118888</pub-id></element-citation></ref><ref id="B61-toxins-09-00390"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieto</surname><given-names>M.</given-names></name><name><surname>Cano</surname><given-names>A.</given-names></name></person-group><article-title>The epithelial-mesenchymal transition under control: Global programs to regulate epithelial plasticity</article-title><source>Semin. Cancer Biol.</source><year>2012</year><volume>22</volume><fpage>361</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1016/j.semcancer.2012.05.003</pub-id><?supplied-pmid 22613485?><pub-id pub-id-type="pmid">22613485</pub-id></element-citation></ref><ref id="B62-toxins-09-00390"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhaskaran</surname><given-names>R.</given-names></name><name><surname>Huang</surname><given-names>C.</given-names></name><name><surname>Chang</surname><given-names>D.</given-names></name><name><surname>Yu</surname><given-names>C.</given-names></name></person-group><article-title>Cardiotoxin III from the Taiwan cobra (<italic>Naja naja atra</italic>). Determination of structure in solution and comparison with short neurotoxins</article-title><source>J. Mol. Biol.</source><year>1994</year><volume>235</volume><fpage>1291</fpage><lpage>1301</lpage><pub-id pub-id-type="doi">10.1006/jmbi.1994.1082</pub-id><?supplied-pmid 8308891?><pub-id pub-id-type="pmid">8308891</pub-id></element-citation></ref><ref id="B63-toxins-09-00390"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chien</surname><given-names>C.</given-names></name><name><surname>Chang</surname><given-names>S.</given-names></name><name><surname>Lin</surname><given-names>K.</given-names></name><name><surname>Chiu</surname><given-names>C.</given-names></name><name><surname>Chang</surname><given-names>L.</given-names></name><name><surname>Lin</surname><given-names>S.</given-names></name></person-group><article-title>Taiwan cobra cardiotoxin III inhibits Src kinase leading to apoptosis and cell cycle arrest of oral squamous cell carcinoma Ca9-22 cells</article-title><source>Toxicon</source><year>2010</year><volume>56</volume><fpage>508</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2010.05.007</pub-id><?supplied-pmid 20493203?><pub-id pub-id-type="pmid">20493203</pub-id></element-citation></ref><ref id="B64-toxins-09-00390"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>K.</given-names></name><name><surname>Su</surname><given-names>J.</given-names></name><name><surname>Chien</surname><given-names>C.</given-names></name><name><surname>Chuang</surname><given-names>P.</given-names></name><name><surname>Chang</surname><given-names>L.</given-names></name><name><surname>Lin</surname><given-names>S.</given-names></name></person-group><article-title>Down-regulation of the JAK2/PI3K-mediated signaling activation is involved in Taiwan cobra cardiotoxin III-induced apoptosis of human breast MDA-MB-231 cancer cells</article-title><source>Toxicon</source><year>2010</year><volume>55</volume><fpage>1263</fpage><lpage>1273</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2010.01.017</pub-id><?supplied-pmid 20144642?><pub-id pub-id-type="pmid">20144642</pub-id></element-citation></ref><ref id="B65-toxins-09-00390"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Lin</surname><given-names>S.</given-names></name><name><surname>Chang</surname><given-names>L.</given-names></name></person-group><article-title>Involvement of mitochondrial alteration and reactive oxygen species generation in Taiwan cobra cardiotoxin-induced apoptotic death of human neuroblastoma SK-N-SH cells</article-title><source>Toxicon</source><year>2008</year><volume>52</volume><fpage>361</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2008.06.013</pub-id><?supplied-pmid 18619991?><pub-id pub-id-type="pmid">18619991</pub-id></element-citation></ref><ref id="B66-toxins-09-00390"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yen</surname><given-names>C.</given-names></name><name><surname>Liang</surname><given-names>S.</given-names></name><name><surname>Han</surname><given-names>L.</given-names></name><name><surname>Chou</surname><given-names>H.</given-names></name><name><surname>Chou</surname><given-names>C.</given-names></name><name><surname>Lin</surname><given-names>S.</given-names></name><name><surname>Chiu</surname><given-names>C.</given-names></name></person-group><article-title>Cardiotoxin III inhibits proliferation and migration of oral cancer cells through MAPK and MMP signaling</article-title><source>Sci. World J.</source><year>2013</year><volume>2013</volume><fpage>650946</fpage><pub-id pub-id-type="doi">10.1155/2013/650946</pub-id><?supplied-pmid 23710144?><pub-id pub-id-type="pmid">23710144</pub-id></element-citation></ref><ref id="B67-toxins-09-00390"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>K.</given-names></name><name><surname>Chien</surname><given-names>C.</given-names></name><name><surname>Hsieh</surname><given-names>C.</given-names></name><name><surname>Tsai</surname><given-names>P.</given-names></name><name><surname>Chang</surname><given-names>L.</given-names></name><name><surname>Lin</surname><given-names>S.</given-names></name></person-group><article-title>Antimetastatic potential of cardiotoxin III involves inactivation of PI3K/Akt and p38 MAPK signaling pathways in human breast cancer MDA-MB-231 cells</article-title><source>Life Sci.</source><year>2012</year><volume>90</volume><fpage>54</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2011.10.020</pub-id><?supplied-pmid 22079475?><pub-id pub-id-type="pmid">22079475</pub-id></element-citation></ref><ref id="B68-toxins-09-00390"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>S.</given-names></name><name><surname>Cabrera</surname><given-names>R.</given-names></name><name><surname>Segall</surname><given-names>J.</given-names></name></person-group><article-title>Tumor cell intravasation</article-title><source>Am. J. Physiol. Cell Physiol.</source><year>2016</year><volume>311</volume><fpage>C1</fpage><lpage>C14</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00238.2015</pub-id><?supplied-pmid 27076614?><pub-id pub-id-type="pmid">27076614</pub-id></element-citation></ref><ref id="B69-toxins-09-00390"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname><given-names>H.</given-names></name><name><surname>Hsu</surname><given-names>S.</given-names></name><name><surname>Xia</surname><given-names>W.</given-names></name><name><surname>Cao</surname><given-names>X.</given-names></name><name><surname>Shih</surname><given-names>J.</given-names></name><name><surname>Wei</surname><given-names>Y.</given-names></name><name><surname>Abbruzzese</surname><given-names>J.</given-names></name><name><surname>Hortobagyi</surname><given-names>G.</given-names></name><name><surname>Hung</surname><given-names>M.</given-names></name></person-group><article-title>Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression</article-title><source>Cancer Res.</source><year>2007</year><volume>67</volume><fpage>9066</fpage><lpage>9076</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-0575</pub-id><?supplied-pmid 17909010?><pub-id pub-id-type="pmid">17909010</pub-id></element-citation></ref><ref id="B70-toxins-09-00390"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balanis</surname><given-names>N.</given-names></name><name><surname>Carlin</surname><given-names>C.</given-names></name></person-group><article-title>Stress-induced EGF receptor signaling through STAT3 and tumor progression in triple-negative breast cancer</article-title><source>Mol. Cell. Endocrinol.</source><year>2017</year><volume>451</volume><fpage>24</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.mce.2017.01.013</pub-id><?supplied-pmid 28088463?><pub-id pub-id-type="pmid">28088463</pub-id></element-citation></ref><ref id="B71-toxins-09-00390"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Kong</surname><given-names>J.</given-names></name><name><surname>Chang</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>A.</given-names></name></person-group><article-title>EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>85021</fpage><lpage>85032</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.13116</pub-id><?supplied-pmid 27829223?><pub-id pub-id-type="pmid">27829223</pub-id></element-citation></ref><ref id="B72-toxins-09-00390"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>P.</given-names></name><name><surname>Hsieh</surname><given-names>C.</given-names></name><name><surname>Chiu</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Chang</surname><given-names>L.</given-names></name><name><surname>Lin</surname><given-names>S.</given-names></name></person-group><article-title>Cardiotoxin III suppresses MDA-MB-231 cell metastasis through the inhibition of EGF/EGFR-mediated signaling pathway</article-title><source>Toxicon</source><year>2012</year><volume>60</volume><fpage>734</fpage><lpage>743</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2012.05.019</pub-id><?supplied-pmid 22683533?><pub-id pub-id-type="pmid">22683533</pub-id></element-citation></ref><ref id="B73-toxins-09-00390"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>P.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Chang</surname><given-names>L.</given-names></name><name><surname>Lin</surname><given-names>S.</given-names></name></person-group><article-title>Taiwan cobra cardiotoxin III suppresses EGF/EGFR-mediated epithelial-to-mesenchymal transition and invasion of human breast cancer MDA-MB-231 cells</article-title><source>Toxicon</source><year>2016</year><volume>111</volume><fpage>108</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2016.01.051</pub-id><?supplied-pmid 26774845?><pub-id pub-id-type="pmid">26774845</pub-id></element-citation></ref><ref id="B74-toxins-09-00390"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>P.</given-names></name><name><surname>Chu</surname><given-names>C.</given-names></name><name><surname>Chiu</surname><given-names>C.</given-names></name><name><surname>Chang</surname><given-names>L.</given-names></name><name><surname>Lin</surname><given-names>S.</given-names></name></person-group><article-title>Cardiotoxin III suppresses hepatocyte growth factor-stimulated migration and invasion of MDA-MB-231 cells</article-title><source>Cell Biochem. Funct.</source><year>2014</year><volume>32</volume><fpage>485</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1002/cbf.3041</pub-id><?supplied-pmid 24964901?><pub-id pub-id-type="pmid">24964901</pub-id></element-citation></ref><ref id="B75-toxins-09-00390"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>P.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Chang</surname><given-names>L.</given-names></name><name><surname>Lin</surname><given-names>S.</given-names></name></person-group><article-title>Cardiotoxin III Inhibits Hepatocyte Growth Factor-Induced Epithelial-Mesenchymal Transition and Suppresses Invasion of MDA-MB-231 Cells</article-title><source>J. Biochem. Mol. Toxicol.</source><year>2016</year><volume>30</volume><fpage>12</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1002/jbt.21735</pub-id><?supplied-pmid 26277884?><pub-id pub-id-type="pmid">26277884</pub-id></element-citation></ref><ref id="B76-toxins-09-00390"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohamed</surname><given-names>M.</given-names></name><name><surname>Sloane</surname><given-names>B.</given-names></name></person-group><article-title>Cysteine cathepsins: Multifunctional enzymes in cancer</article-title><source>Nat. Rev. Cancer</source><year>2006</year><volume>6</volume><fpage>764</fpage><lpage>775</lpage><pub-id pub-id-type="doi">10.1038/nrc1949</pub-id><?supplied-pmid 16990854?><pub-id pub-id-type="pmid">16990854</pub-id></element-citation></ref><ref id="B77-toxins-09-00390"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fonovi&#x00107;</surname><given-names>M.</given-names></name><name><surname>Turk</surname><given-names>B.</given-names></name></person-group><article-title>Cysteine cathepsins and extracellular matrix degradation</article-title><source>Biochim. Biophys. Acta</source><year>2014</year><volume>1840</volume><fpage>2560</fpage><lpage>2570</lpage><pub-id pub-id-type="doi">10.1016/j.bbagen.2014.03.017</pub-id><?supplied-pmid 24680817?><pub-id pub-id-type="pmid">24680817</pub-id></element-citation></ref><ref id="B78-toxins-09-00390"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f6;ser</surname><given-names>R.</given-names></name><name><surname>Pietzsch</surname><given-names>J.</given-names></name></person-group><article-title>Cysteine cathepsins: Their role in tumor progression and recent trends in the development of imaging probes</article-title><source>Front. Chem.</source><year>2015</year><volume>3</volume><fpage>37</fpage><pub-id pub-id-type="doi">10.3389/fchem.2015.00037</pub-id><?supplied-pmid 26157794?><pub-id pub-id-type="pmid">26157794</pub-id></element-citation></ref><ref id="B79-toxins-09-00390"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soboti&#x0010d;</surname><given-names>B.</given-names></name><name><surname>Vizovi&#x00161;ek</surname><given-names>M.</given-names></name><name><surname>Vidmar</surname><given-names>R.</given-names></name><name><surname>Van Damme</surname><given-names>P.</given-names></name><name><surname>Gocheva</surname><given-names>V.</given-names></name><name><surname>Joyce</surname><given-names>J.</given-names></name><name><surname>Gevaert</surname><given-names>K.</given-names></name><name><surname>Turk</surname><given-names>V.</given-names></name><name><surname>Turk</surname><given-names>B.</given-names></name><name><surname>Fonovi&#x00107;</surname><given-names>M.</given-names></name></person-group><article-title>Proteomic Identification of Cysteine Cathepsin Substrates Shed from the Surface of Cancer Cells</article-title><source>Mol. Cell. Proteom.</source><year>2015</year><volume>14</volume><fpage>2213</fpage><lpage>2228</lpage><pub-id pub-id-type="doi">10.1074/mcp.M114.044628</pub-id><?supplied-pmid 26081835?><pub-id pub-id-type="pmid">26081835</pub-id></element-citation></ref><ref id="B80-toxins-09-00390"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gocheva</surname><given-names>V.</given-names></name><name><surname>Zeng</surname><given-names>W.</given-names></name><name><surname>Ke</surname><given-names>D.</given-names></name><name><surname>Klimstra</surname><given-names>D.</given-names></name><name><surname>Reinheckel</surname><given-names>T.</given-names></name><name><surname>Peters</surname><given-names>C.</given-names></name><name><surname>Hanahan</surname><given-names>D.</given-names></name><name><surname>Joyce</surname><given-names>J.</given-names></name></person-group><article-title>Distinct roles for cysteine cathepsin genes in multistage tumorigenesis</article-title><source>Genes Dev.</source><year>2006</year><volume>20</volume><fpage>543</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1101/gad.1407406</pub-id><?supplied-pmid 16481467?><pub-id pub-id-type="pmid">16481467</pub-id></element-citation></ref><ref id="B81-toxins-09-00390"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedl</surname><given-names>P.</given-names></name><name><surname>Alexander</surname><given-names>S.</given-names></name></person-group><article-title>Cancer invasion and the microenvironment: Plasticity and reciprocity</article-title><source>Cell Biochem. Funct.</source><year>2011</year><volume>147</volume><fpage>992</fpage><lpage>1009</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.11.016</pub-id><?supplied-pmid 22118458?><pub-id pub-id-type="pmid">22118458</pub-id></element-citation></ref><ref id="B82-toxins-09-00390"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jedeszko</surname><given-names>C.</given-names></name><name><surname>Sloane</surname><given-names>B.</given-names></name></person-group><article-title>Cysteine cathepsins in human cancer</article-title><source>Biol. Chem.</source><year>2004</year><volume>385</volume><fpage>1017</fpage><lpage>1027</lpage><pub-id pub-id-type="doi">10.1515/BC.2004.132</pub-id><?supplied-pmid 15576321?><pub-id pub-id-type="pmid">15576321</pub-id></element-citation></ref><ref id="B83-toxins-09-00390"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shamsi</surname><given-names>A.</given-names></name><name><surname>Bano</surname><given-names>B.</given-names></name></person-group><article-title>Journey of cystatins from being mere thiol protease inhibitors to at heart of many pathological conditions</article-title><source>Int. J. Biol. Macromol.</source><year>2017</year><volume>102</volume><fpage>674</fpage><lpage>693</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2017.04.071</pub-id><?supplied-pmid 28445699?><pub-id pub-id-type="pmid">28445699</pub-id></element-citation></ref><ref id="B84-toxins-09-00390"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brillard-Bourdet</surname><given-names>M.</given-names></name><name><surname>Nguy&#x000ea;n</surname><given-names>V.</given-names></name><name><surname>Ferrer-di Martino</surname><given-names>M.</given-names></name><name><surname>Gauthier</surname><given-names>F.</given-names></name><name><surname>Moreau</surname><given-names>T.</given-names></name></person-group><article-title>Purification and characterization of a new cystatin inhibitor from Taiwan cobra (<italic>Naja naja atra</italic>) venom</article-title><source>Biochem. J.</source><year>1998</year><volume>331</volume><fpage>239</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1042/bj3310239</pub-id><?supplied-pmid 9512485?><pub-id pub-id-type="pmid">9512485</pub-id></element-citation></ref><ref id="B85-toxins-09-00390"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>N.</given-names></name><name><surname>Xie</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Lin</surname><given-names>X.</given-names></name><name><surname>Lin</surname><given-names>J.</given-names></name></person-group><article-title>Inhibition of invasion and metastasis of MHCC97H cells by expression of snake venom cystatin through reduction of proteinases activity and epithelial-mesenchymal transition</article-title><source>Arch. Pharm. Res.</source><year>2011</year><volume>34</volume><fpage>781</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1007/s12272-011-0512-6</pub-id><?supplied-pmid 21656364?><pub-id pub-id-type="pmid">21656364</pub-id></element-citation></ref><ref id="B86-toxins-09-00390"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayor</surname><given-names>R.</given-names></name><name><surname>Etienne-Manneville</surname><given-names>S.</given-names></name></person-group><article-title>The front and rear of collective cell migration</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2016</year><volume>17</volume><fpage>97</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1038/nrm.2015.14</pub-id><?supplied-pmid 26726037?><pub-id pub-id-type="pmid">26726037</pub-id></element-citation></ref><ref id="B87-toxins-09-00390"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zegers</surname><given-names>M.</given-names></name><name><surname>Friedl</surname><given-names>P.</given-names></name></person-group><article-title>Rho GTPases in collective cell migration</article-title><source>Small GTPases</source><year>2014</year><volume>5</volume><fpage>e28997</fpage><pub-id pub-id-type="doi">10.4161/sgtp.28997</pub-id><?supplied-pmid 25054920?><pub-id pub-id-type="pmid">25054920</pub-id></element-citation></ref><ref id="B88-toxins-09-00390"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sartim</surname><given-names>M.</given-names></name><name><surname>Sampaio</surname><given-names>S.</given-names></name></person-group><article-title>Snake venom galactoside-binding lectins: A structural and functional overview</article-title><source>J. Venom. Anim. Toxins Incl. Trop. Dis.</source><year>2015</year><volume>21</volume><fpage>35</fpage><pub-id pub-id-type="doi">10.1186/s40409-015-0038-3</pub-id><?supplied-pmid 26413085?><pub-id pub-id-type="pmid">26413085</pub-id></element-citation></ref><ref id="B89-toxins-09-00390"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pathan</surname><given-names>J.</given-names></name><name><surname>Mondal</surname><given-names>S.</given-names></name><name><surname>Sarkar</surname><given-names>A.</given-names></name><name><surname>Chakrabarty</surname><given-names>D.</given-names></name></person-group><article-title>Daboialectin, a C-type lectin from Russell&#x02019;s viper venom induces cytoskeletal damage and apoptosis in human lung cancer cells in vitro</article-title><source>Toxicon</source><year>2017</year><volume>127</volume><fpage>11</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2016.12.013</pub-id><?supplied-pmid 28062165?><pub-id pub-id-type="pmid">28062165</pub-id></element-citation></ref><ref id="B90-toxins-09-00390"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>D.</given-names></name><name><surname>Marangoni</surname><given-names>S.</given-names></name><name><surname>Oliveira</surname><given-names>B.</given-names></name><name><surname>Novello</surname><given-names>J.</given-names></name></person-group><article-title>Isolation and characterization of a new lectin from the venom of the snake <italic>Bothrops jararacussu</italic></article-title><source>IUBMB Life</source><year>1998</year><volume>44</volume><fpage>933</fpage><lpage>938</lpage><pub-id pub-id-type="doi">10.1080/15216549800201992</pub-id></element-citation></ref><ref id="B91-toxins-09-00390"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nolte</surname><given-names>S.</given-names></name><name><surname>de Castro Damasio</surname><given-names>D.</given-names></name><name><surname>Bar&#x000e9;a</surname><given-names>A.</given-names></name><name><surname>Gomes</surname><given-names>J.</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>A.</given-names></name><name><surname>Mello Zischler</surname><given-names>L.</given-names></name><name><surname>Stuelp-Campelo</surname><given-names>P.</given-names></name><name><surname>El&#x000ed;fio-Esposito</surname><given-names>S.</given-names></name><name><surname>Roque-Barreira</surname><given-names>M.</given-names></name><name><surname>Reis</surname><given-names>C.</given-names></name><etal/></person-group><article-title>BJcuL, a lectin purified from <italic>Bothrops jararacussu</italic> venom, induces apoptosis in human gastric carcinoma cells accompanied by inhibition of cell adhesion and actin cytoskeleton disassembly</article-title><source>Toxicon</source><year>2012</year><volume>59</volume><fpage>81</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2011.10.012</pub-id><?supplied-pmid 22079298?><pub-id pub-id-type="pmid">22079298</pub-id></element-citation></ref><ref id="B92-toxins-09-00390"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Carvalho</surname><given-names>D.</given-names></name><name><surname>Schmitmeier</surname><given-names>S.</given-names></name><name><surname>Novello</surname><given-names>J.</given-names></name><name><surname>Markland</surname><given-names>F.</given-names></name></person-group><article-title>Effect of BJcuL (a lectin from the venom of the snake <italic>Bothrops jararacussu</italic>) on adhesion and growth of tumor and endothelial cells</article-title><source>Toxicon</source><year>2001</year><volume>39</volume><fpage>1471</fpage><lpage>1476</lpage><pub-id pub-id-type="doi">10.1016/S0041-0101(01)00106-4</pub-id><pub-id pub-id-type="pmid">11478954</pub-id></element-citation></ref><ref id="B93-toxins-09-00390"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peichoto</surname><given-names>M.E.</given-names></name><name><surname>Teibler</surname><given-names>P.</given-names></name><name><surname>Mackessy</surname><given-names>S.P.</given-names></name><name><surname>Leiva</surname><given-names>L.</given-names></name><name><surname>Acosta</surname><given-names>O.</given-names></name><name><surname>Goncalves</surname><given-names>L.R.</given-names></name><name><surname>Tanaka-Azevedo</surname><given-names>A.M.</given-names></name><name><surname>Santoro</surname><given-names>M.L.</given-names></name></person-group><article-title>Purification and characterization of patagonfibrase, a metalloproteinase showing alpha-fibrinogenolytic and hemorrhagic activities, from <italic>Philodryas patagoniensis</italic> snake venom</article-title><source>BBA Gen. Subj.</source><year>2007</year><volume>1770</volume><fpage>810</fpage><lpage>819</lpage><pub-id pub-id-type="doi">10.1016/j.bbagen.2006.12.014</pub-id><?supplied-pmid 17306461?><pub-id pub-id-type="pmid">17306461</pub-id></element-citation></ref><ref id="B94-toxins-09-00390"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e1;nchez</surname><given-names>M.N.</given-names></name><name><surname>Timoniuk</surname><given-names>A.</given-names></name><name><surname>Maru&#x000f1;ak</surname><given-names>S.</given-names></name><name><surname>Teibler</surname><given-names>P.</given-names></name><name><surname>Acosta</surname><given-names>O.</given-names></name><name><surname>Peichoto</surname><given-names>M.E.</given-names></name></person-group><article-title>Biochemical and biological analysis of <italic>Philodryas baroni</italic> (Baron&#x02019;s Green Racer; Dipsadidae) venom: Relevance to the findings of human risk assessment</article-title><source>Hum. Exp. Toxicol.</source><year>2014</year><volume>33</volume><fpage>22</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1177/0960327113493302</pub-id><?supplied-pmid 23800999?><pub-id pub-id-type="pmid">23800999</pub-id></element-citation></ref><ref id="B95-toxins-09-00390"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heyborne</surname><given-names>W.H.</given-names></name><name><surname>Mackessy</surname><given-names>S.P.</given-names></name></person-group><article-title>Identification and characterization of a taxon-specific three-finger toxin from the venom of the Green Vinesnake (<italic>Oxybelis fulgidus</italic>; family Colubridae)</article-title><source>Biochimie</source><year>2013</year><volume>95</volume><fpage>1923</fpage><lpage>1932</lpage><pub-id pub-id-type="doi">10.1016/j.biochi.2013.06.025</pub-id><?supplied-pmid 23851011?><pub-id pub-id-type="pmid">23851011</pub-id></element-citation></ref><ref id="B96-toxins-09-00390"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhowmik</surname><given-names>T.</given-names></name><name><surname>Saha</surname><given-names>P.</given-names></name><name><surname>Sarkar</surname><given-names>A.</given-names></name><name><surname>Gomes</surname><given-names>A.</given-names></name></person-group><article-title>Evaluation of cytotoxicity of a purified venom protein from <italic>Naja kaouthia</italic> (NKCT1) using gold nanoparticles for targeted delivery to cancer cell</article-title><source>Chem. Biol. Interact.</source><year>2017</year><volume>261</volume><fpage>35</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2016.11.007</pub-id><?supplied-pmid 27836789?><pub-id pub-id-type="pmid">27836789</pub-id></element-citation></ref><ref id="B97-toxins-09-00390"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badr</surname><given-names>G.</given-names></name><name><surname>Sayed</surname><given-names>D.</given-names></name><name><surname>Maximous</surname><given-names>D.</given-names></name><name><surname>Mohamed</surname><given-names>A.</given-names></name><name><surname>Gul</surname><given-names>M.</given-names></name></person-group><article-title>Increased susceptibility to apoptosis and growth arrest of human breast cancer cells treated by a snake venom-loaded silica nanoparticles</article-title><source>Cell. Physiol. Biochem.</source><year>2014</year><volume>34</volume><fpage>1640</fpage><lpage>1651</lpage><pub-id pub-id-type="doi">10.1159/000366366</pub-id><?supplied-pmid 25401286?><pub-id pub-id-type="pmid">25401286</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="toxins-09-00390-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p><bold>Anti-metastatic targets for snake toxins.</bold> Snake toxins inhibit pro-migratory and pro-invasive signals stimulated by extracellular matrix proteins and growth factors such as epidermal growth factor (EGF), hepatocyte growth factor (HGF), and transforming growth factor beta (TGF-&#x003b2;) though (1) inhibition of extracellular matrix (ECM) components-dependent adhesion and migration, (2) inhibition of migration by alterations in the actin/cytoskeleton network, and (3) inhibition of epithelial&#x02013;mesenchymal transition (EMT). Dis: disintegrins; CLP: C-type lectin-like proteins; KSP: Kunitz-type serinprotease; C-Lectins: C-type lectins; CTX-III: cardiotoxin III; Sv-cystatin: snake venom cystatin.</p></caption><graphic xlink:href="toxins-09-00390-g001"/></fig><table-wrap id="toxins-09-00390-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">toxins-09-00390-t001_Table 1</object-id><label>Table 1</label><caption><p>Snake toxins that inhibit the adhesion and migration of cancer cells by interaction with ECM components.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Toxin Name</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Snake Species</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Adhesive Motif</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Integrin Target</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">ECM Ligand</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Effect</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">r-Cam-dis recombinant disintegrin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Crotalus adamanteus</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RGD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;v&#x003b2;3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">laminin-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of adhesion in pancreatic cancer cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B41-toxins-09-00390" ref-type="bibr">41</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">r-Colombistatins recombinant disintegrin-like domains from Class-III SVMP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Bothrops colombiensis</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ECD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">collagen I</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of adhesion in SK-Mel-28 melanoma cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B42-toxins-09-00390" ref-type="bibr">42</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DisBa-01, recombinant disintegrin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Bothrops alternatus</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RGD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;v&#x003b2;3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">fibronectin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Loss of cell directionality of migrating oral squamous carcinoma cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B43-toxins-09-00390" ref-type="bibr">43</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">r-mojastn-1, recombinant disintegrin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Crotalus scutulatus scutulatus</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RGD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;v&#x003b2;3, &#x003b1;3, and &#x003b2;1,</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">fibronectin and vitronectin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of adhesion and migration of BXPC-3 pancreatic cancer cell line</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B44-toxins-09-00390" ref-type="bibr">44</xref>,<xref rid="B45-toxins-09-00390" ref-type="bibr">45</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">r-viridistatin-2, recombinant disintigrin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Crotalus viridis viridis</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RGD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;v&#x003b2;3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">fibronectin and vitronectin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of adhesion, migration and invasion of several cancer cell lines </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B44-toxins-09-00390" ref-type="bibr">44</xref>,<xref rid="B46-toxins-09-00390" ref-type="bibr">46</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lebecin, C-type lectin-like protein</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Macrovipera lebetina</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;v&#x003b2;3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">fibronectin and fibrinogen</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of adhesion and migration of MDA-MB-231 breast cancer cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B47-toxins-09-00390" ref-type="bibr">47</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PIVL, Kunitz-type serin protease inhibitor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Macrovipera lebetina transmediterranea</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RGN</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;v&#x003b2;3 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">fibronectin and fibrinogen</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of adhesion, migration and invasion of human glioblastoma U87 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-toxins-09-00390" ref-type="bibr">48</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>n.d.: not determined.</p></fn></table-wrap-foot></table-wrap></floats-group></article>